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Zusammenfassung 
Kollagene sind eine äußerst vielseitige Superfamilie von Proteinen, welche primär als strukturgebende 
Hauptkomponente der Extrazellulären Matrix (EM) von Metazoen bekannt sind. Aufgrund ihrer 
zentralen Rolle beim Aufbau und der Dynamik der EM sind Kollagene an einer Vielzahl an 
unterschiedlichen Prozessen wie z.B. der Zelladhäsion, Zellmigration, Angiogenese, Morphogenese, 
Immunantwort oder Krebsprogression beteiligt. Die Biosynthese dieser großen, stark post-translational 
modifizierten Proteine wird durch eine fein aufeinander abgestimmte Maschinerie bewerkstelligt. Die 
Komplexität dieser Maschinerie äußert sich durch ihre Anfälligkeit gegenüber Störungen, welche oft 
zur Entstehung von schwerwiegenden Defekten und Krankheiten führen. Das molekulare Chaperon von 
Kollagen, Hitzeschockprotein 47 (HSP47), spielt hierbei eine entscheidende Rolle und gewährleistet 
sowohl die fehlerfreie Synthese und den Transport von Kollagenen als auch den Schutz des 
Endoplasmatischen Retikulums (ER) vor durch Aggregation und Akkumulation von Kollagenen 
bedingtem Stress. Obwohl HSP47 seit mehr als zwei Jahrzehnten Forschungsgegenstand ist, sind viele, 
teilweise grundlegende Aspekte seiner Funktion immer noch unbekannt; es ist z.B. unbekannt, welchen 
Vorteil die Serinproteasestruktur für die Proteinfunktion bringt, oder ob alle Kollagentypen zum 
Substratrepertoire gehören. Die kürzlich gelöste Kristallstruktur von HSP47 im Komplex mit einem 
Kollagenmodellpeptid hat der Beantwortung der offenen Fragen neuen Anstoß gegeben. Eine betrifft 
den Mechanismus der Substratfreisetzung: untypisch für Chaperone wird die Funktion von HSP47 nicht 
durch Austausch oder Hydrolyse von Nukleotiden reguliert, sondern durch die graduelle Abnahme des 
pH-Wertes im sekretorischen Weg. Die molekularen Details dieser pH-induzierten Substratfreisetzung 
sind ungeklärt und wurden im ersten Teil der vorliegenden Arbeit untersucht. Ausgehend von der 
Kristallstruktur und Phylogenetischen Daten wurden gezielt HSP47-Punktmutanten generiert und deren 
Bindung an Kollagenmodellpeptide mittels Biolayerinterferometrie kinetisch quantifiziert. Besonderes 
Interesse galt hierbei den 14 Histidinresten von HSP47, welche Aufgrund Ihrer Fähigkeit, bei 
physiologischen pH-Werten Protonen aufnehmen zu können, als potentielle Auslöser einer 
Substratfreisetzung in Betracht kamen. Eine systematische Analyse dieser Aminosäuren enthüllte dass 
His273 und His274, am Rande der Interaktionsfläche gelegen, großen Einfluss auf die pH-Sensitivität 
der HSP47 - Kollagen Interaktion ausüben. Andere Histidinreste wurden ebenfalls als wichtige 
Komponenten der Interaktion ausgemacht, wie z.B. His238, welches bei der korrekten Ausrichtung  von 
für die Bindung essentiellen Aminosäureseitenketten eine Rolle spielt. Versuche, HSP47 bei leicht 
saurem Milieu zu Kristallisieren waren Aufgrund der verminderten Stabilität des Proteins unter solchen 
Bedingungen nicht erfolgreich; somit steht eine umfassende, strukturelle Erklärung des 
Substratfreisetzungsmechanismus noch aus. 
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In den letzten Jahren haben mehrere Studien gezeigt, dass Genablation von HSP47 mittels siRNA zu 
einer deutlichen Verbesserung bis hin zur Aufhebung von fibrotischen Krankheiten führen kann. HSP47 
wurde dadurch als ein vielversprechendes Ziel für die Entwicklung antifibrotischer Medikamente 
erkannt. Vor diesem Hintergrund wurde in dieser Arbeit ein auf Fluoreszenz basierender Assay 
entwickelt, welcher mittels eines Hochdurchsatzverfahens zur Identifizierung neuartiger Inhibitoren des 
HSP47 - Kollagen Komplexes herangezogen werden kann. Der Assay wurde genutzt, um aus einer 
40.000 Chemikalien umfassenden Substanzbibliothek heraus 4 potentielle Inhibitorkandidaten zu 
identifizieren, von welchen mindestens eine Substanz in Validationsexperimenten vielversprechende 
Ergebnisse lieferte. 
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Abstract 
Collagens are a multifaceted superfamily of proteins which constitute the principal structural 
component of the extracellular matrix (ECM) of metazoan organisms. Intimately tied to ECM 
architecture and dynamics, collagens are involved in a multitude of processes such as cell adhesion and 
migration, angiogenesis, morphogenesis, the immune response and cancer progression. The 
biosynthesis of these large and complex molecules is reliant on a finely tuned machinery, disruptions 
of which is often causative to severe disease. Heat-shock protein 47 (HSP47), the molecular chaperone 
of collagen, plays a central role in ensuring proper processing and trafficking of collagens as well as 
the protection of the endoplasmatic reticulum (ER) from stress induced by aggregation and 
accumulation of its client. Although HSP47 has been first described more than 20 years ago, critical 
aspects of its function are still shrouded in mystery, ranging from why it is a member of the serpin 
superfamily of proteins to whether its client repertoire includes all types of collagen. The rather recently 
solved crystal structure of HSP47 in complex with a collagen model peptide has provided a new impetus 
for answering the many open questions. One of these is how client-release is achieved: untypical for 
chaperones, HSP47 function is not coupled to nucleotide hydrolysis or exchange, but governed by the 
gradual decrease in pH along the secretory pathway. The mechanism by which the pH-shift induces 
client release is unclear. In this work, it was investigated whether this process is based on 
conformational re-arrangements, more subtle distortions of the binding site or electrostatic repulsion. 
Of particular interest were the 14 histidine residues in HSP47, which have long been considered as 
potential trigger residues, since their imidazole side-chains can serve as a proton acceptor at 
physiological pH. Systematic analysis of these histidines in context of this thesis has revealed that 
His273 and His274, located at the fringe of the binding interface, exert considerable influence on the 
pH-sensitivity of the HSP47 - collagen complex. Other histidines have also been found to be important 
for the interaction; most notably, His238 was shown to be an essential actor in the pre-arrangement of 
key residues in a client-binding competent conformation. 
Over the recent years, studies using gene ablation via siRNA have shown that interfering with the 
HSP47 - collagen complex can resolve a variety of fibrotic diseases. HSP47 has thus enjoyed increasing 
attention as a potential target for anti-fibrotic drugs. In light of this, one part of this thesis has focused 
on developing a fluorescence based, high-throughput screening compatible assay to be utilized for the 
identification of novel inhibitors of the HSP47 - collagen interaction. Interrogation of a compound 
library using the assay has yielded 4 potential inhibitor candidates, at least one of which having shown 
promising results in initial validation studies.
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1. Introduction 
1.1 Collagen 
1.1.1 The Collagen Superfamily: An Overview 
Collagens are a remarkably diverse superfamily of proteins which are best known for their prominent 
role in the architecture of the extracellular matrix (ECM) of animals. Collagen is the most abundant 
protein in vertebrates, constituting almost a third of total protein mass - a consequence of the ubiquity 
of the extracellular matrix and the markedly low turnover of many collagens, some of which being 
practically permanent, as for instance collagens in adult cartilaginous tissue1. By and large the principal 
function of collagens is to provide structural integrity and scaffolding to the extracellular space. 
Collagens fulfil this role via assembling into various superstructures with extraordinary mechanical 
properties: the elastic modulus of a single collagen I fibril from rat tail, for instance, has been determined 
to be in the range of 1-10 GPa, coming close to that of typical metals and showcasing formidable tensile 
strength at a much lower density2. Besides these well-characterized structural roles, collagens are also 
involved in a multitude of dynamic phenomena such as cellular adhesion, migration or chemotaxis. 
Products of collagen processing are often important biochemical effectors: endostatin, a C-terminal 
domain of multiplexin collagens, has been shown to inhibit angiogenesis upon proteolytic release and 
is currently in clinical trials as an anti-tumour agent3,4, while the C-propeptide of collagen type I is 
believed to play a key regulatory role both in fibrillogenesis and collagen biosynthesis5. Similarly, 
membrane collagens are known not only to function as cell surface receptors but also serve as a reservoir 
for effectors in the form of shed ectodomains. Another example for the multifaceted nature of collagens 
is collagen type VI, which besides forming beaded filaments, an important structural element of the 
ECM, is also capable of disrupting bacterial membranes and as such involved in innate host defense of 
the ECM6. 
Despite its omnipresence and biochemical significance, the definition of what is a collagen and what is 
not is still blurry at best. Three features are widely considered to be hallmarks of collagens7:  
(i) The presence of at least one so-called collagenous domain, characterized by a triple- 
helical structure comprised of three separate polypeptide chains with repeating triplets 
of Gly-Xaa-Yaa (Xaa, Yaa = any amino acid), 
(ii) Localization in the extracellular space, and  
(iii) Participation in the assembly of superstructures.  
These hallmarks are not always sufficient to fully characterize collagens, though, since there are 
exceptions aplenty: membrane collagens, for example, do not assemble into superstructures and are 
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strictly seen components of the cell membrane. The triple-helical structural motif, on the other hand, is 
also encountered in other proteins such as adiponectin, the asymetric form of acetylcholinesterase, C1q, 
macrophage scavenger receptors (MARCO), ficolins, collectins and many others7. Emilins and emu 
proteins fulfil all three criteria of being collagens, but are not (yet) classified as such8.   
Collagens and related molecules are not exclusive to vertebrates and have been discovered in many 
different multicellular organisms, including primordial forms of life such as Sponges9 and Hydra10, or 
rather extraordinary ones, such as the annelid Alvinella pompeiana, one of the most heat-tolerant 
metazoan known to date11. A single, 54 bp long sequence is believed to be ancestral to fibrillar 
collagens, which subsequently arose via multiple duplications of this basic genetic unit10,12. Such 
collagen-related structural motifs (CSM), although rare, are also found in unicellular eukaryotes and 
bacteria13; the streptococcal cell surface proteins Scl1 and Scl2, for instance, contain extended Gly-Xaa-
Yaa repeats in their amino acid sequences10, as does the exosporium filament BclA of Bacillus 
anthracis14,15. An intact collagen gene has even been discovered in the viral shrimp pathogen White 
Spot Bacilliform Virus16.  It is quite possible that prokaryotic and viral collagen genes are the result of 
horizontal gene transfer and that the appearance of collagens is tied to the emergence of a hypothetical 
ancestor of metazoans9; this would imply that the acquisition and retention of such genes by unicellular 
organisms provides advantages in the interaction with multicellular hosts.   
1.1.2 Composition and Classification of Collagens 
Collagens are multidomain proteins comprised of three individual polypeptide chains, called collagen 
α-chains. The primary structure of α-chains characteristically includes extended regions consisting of 
repeating Gly-Xaa-Yaa triplets, where Xaa is frequently proline (28%) and Yaa (2S,4R)-4-
hydroxyproline (38%)17. As will be discussed in more detail below, these proline-rich regions are 
responsible for the formation of the distinctive collagen triple-helix. In collagens, extensive triple-
helical stretches, called collagenous domains, are typically interspersed with short non-collagenous (i.e. 
non triple-helical) domains, referred to as interruptions, and flanked by globular N- and C-terminal 
domains. A testament to the complexity of collagens, the identity and processing of these N- and C-
terminal domains can vary greatly between different types of collagens. 
As of today, 28 types of collagens (designated with Roman numerals I-XXVIII) with a total of 46 
unique* α-chains have been characterized in humans (The “novel” collagen α-chain XXIX α1 turned 
out to be identical to collagen VI α5). For most collagen types, only one α-chain is known; others have 
multiple unique α-chains (up to 6 for collagen IV, and collagen VI in some mammals) which are 
distinguished via Arabic numerals. Since some collagens have several isoforms with differing chain 
compositions and others even form hybrid structures with α-chains of different collagens, the exact 
definition of a collagen molecule requires the specification of all three incorporated α-chains (e.g.  
*α1(II) and α3(XI) share the same sequence but diverge in posttranslational processing and cross-linking18. 
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[α1(I)]3 for homotrimeric collagen type I and [α1(I)]2, α2(I)] for heterotrimeric collagen type I).  
Collagens are commonly classified according to their domain organization and/or the superstructures 
they form. The subfamilies include fibril forming collagens (I, II, III, V, XI, XXIV and XXVII), fibril 
associated collagens with interrupted triple-helices (FACIT) (IX, XII, XIV, XVI, XIX, XX, XXI, 
XXII), membrane associated collagens with interrupted triple-helices (MACIT) (XIII, XVII, XXIII, 
XXV), collagens with multiple triple-helical domains with interruptions (Multiplexins) (XV, XVIII), 
and network forming collagens (IV, VIII, X). Furthermore, there are collagens forming beaded 
filaments (collagen VI) and anchoring fibrils (collagen VII) as well as some which do not quite fit into 
any category (XXVI, XXVIII). Since a detailed discussion of the differences in structure and 
biosynthesis between these classes of collagens would be beyond the scope of this work, the following 
sections will focus on fibril forming collagens, which are the best characterized and have been subject 
to study in this work. 
Fibril Forming Collagens 
Fibrillar collagens are the most abundant in terms of total protein mass: collagen type I alone comprises 
more than 90% of all collagen in the body. The subfamily encompasses collagens of type I, II and III 
(type A clade, also called major fibrillar collagens in regard to their quantity), collagens type V and XI 
(type B clade, minor fibrillar collagens) and finally the novel collagens type XXIV and XXVII (type C 
clade)19. The latter are rather similar to collagens found in invertebrates, being shorter and containing 
imperfections/interruptions in their triple-helical domain20.  
Figure 1.1 shows the domain organization of a prototypical fibrillar collagen. Collagenous domains 
(COL) and non-collagenous domains (NC) are numbered proceeding from C- to N-terminus (this is 
consistent for all fibrillar collagens, but there are cases in which the numbering is reversed, such as 
MACIT collagen type XIII). Fibrillar collagens of the same clade typically share N-terminal NC 
domains: these are homologous to von Willebrand factor type C (vWFC, also called chordin-like 
cysteine rich repeats) in members of clade A and to thrombospondin-1 N-terminus-like domain (TSPN)  
 
 
 
 
 
Figure 1.1│Domain organization of a prototypical fibrillar collagen. An extended and in most cases 
uninterrupted collagenous domain (COL1) is flanked N- and C-terminally by non-collagenous domains (NC2 and 
NC1, respectively). Proteolytic cleavage within the NC2 region results in release of the N-propeptide, consisting 
of a short collagenous domain (COL2) and a globular domain (NC3), usually TSPN or vWFC. The C-propeptide 
is synonymous with the NC1 domain. 
NC1 
COL1 
NC2 
COL2 
NC3 
N-propeptide 
Globular 
domains 
Interruption in 
Triple-helix 
Triple-helical 
domain 
C-propeptide 
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in members of clades B and C19. Unsurprisingly for collagens, there are exceptions: the N-terminal NC 
domain seems to have been deleted in case of α2(I), and α2(V) harbors a cysteine-rich repeat even 
though it belongs to clade B. The C-terminal NC1 domain, however, is highly conserved among fibrillar 
collagens and is important for trimerization and correct registration during collagen maturation.  
1.1.3 Structure and Stability of the Collagenous Domain 
The Polyproline Helix Type II 
The PPII helix is a much neglected secondary structure element that is not only encountered in fibrillar 
proteins such as collagen, but is also widely dispersed in natively folded globular proteins, most often 
over short stretches of 4 or 5 amino acids and frequently preceding/transitioning into α-helices, β-sheets, 
310-helices or reverse turns21. Analysis of protein structures deposited to the Protein Data Bank archive 
(PDB) of the Research Collaboratory for Structural Bioinformatics (RCSB) shows that around 2% of 
amino acids are incorporated into PPII helices22. The PPII helix is particularly important as the structural 
motif which is recognized by the abundant proline recognition domains such as SH3, WW or EVH123,24. 
The PPII helical conformation is furthermore believed to be dominant in unfolded proteins25, short 
polypeptides and regions of proteins previously assumed unstructured26. Raman spectroscopic studies 
also suggest that the PPII helix is an important transitory element in protein folding and denaturation, 
having been observed during the melting of α-helices in peptides27 as well as the transformation of an  
α-helix in native human lysozyme into a β-sheet strand involved in amyloidogenesis28. 
The PPII helix is an elongated, left handed helix encompassing 3 residues per turn with a helical pitch 
of 3.1 Å per residue. In its ideal form, it is defined by the backbone dihedral angles φ= -75°, ψ= 145° 
and ω = 180° (all-trans conformation). As the name suggests, proline residues have a high propensity 
to form PPII helices. This is a consequence of the pyrrolidine ring restricting φ to a region suitable for 
PPII helix formation (-75 ± 15°), thus leading to a decreased loss of conformational entropy upon 
assuming the ordered structure.  It should be noted though that the above mentioned angles correspond 
to Ramachandran regions which are populated by all amino acids, meaning that proline residues are not 
an absolute requirement for PPII helix formation.  
The PPII helix lacks the backbone hydrogen bonds characteristic of the other secondary structure 
elements, and the factors governing its stability have long been disputed. One important aspect are steric 
interactions and restrictions: the region of φ and ψ populated by amino acids in a PPII helix 
characteristically lacks unfavourable steric interactions29, as would be intuitive considering the  
elongated, well-spaced structure of the helix with all side chains pointing away from the helical axis. 
Furthermore, steric effects alone have been sufficient to drive PPII helix formation in Monte Carlo 
simulations, with the important interactions having been pinpointed to occur between the pyrrolidine 
moiety of proline residues and the backbone of the preceding amino acid30. Another factor contributing 
to the stability is the high degree of solvation, especially of the backbone carbonyl and amide groups, 
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which are aligned perpendicular to the helical axis and highly exposed. This is underlined, inter alia, by 
the correlation observed between solvent-accessible surface area and PPII formation propensity31. The 
side chains of the amino acids are also observed to influence the stability of the helix: the strong 
tendency of Gln residues to form PPII helices, for instance, has been explained with intermolecular 
hydrogen bonds formed between the amide hydrogen of the side-chain and the backbone carbonyl of 
the C-terminally neighboring amino acid.32 Another stabilizing effect yet comes in the form of a n → 
π* interaction, in which overlap between the non-bonding orbital of a carbonyl-oxygen with the anti-
bonding π* orbital of the carbonyl moiety of a C-terminally neighbouring residue leads to a stabilization 
of an estimated 0.7 kcal/mol via electron delocalization33,34. 
The Collagen Triple-helix 
The molecular structure of this defining element of collagens has been extensively characterized in the 
past - the classical collagen model peptide [(Pro-Pro-Gly)10]3 has even made it aboard the space shuttle 
Discovery, where crystals were grown under micro-gravity35, which back on earth resulted in structure 
determination with a respectable 1.3Å resolution and an R-factor of 0.1836. The collagen triple-helix is 
comprised of three parallel PPII helices, supercoiled along a common axis to form a right handed triple 
helix with a helical pitch ranging from 7/2 for proline-rich regions to 10/3 for proline-poor regions17. 
The α-chains are axially staggered by one amino acid and thus can be distinguished as leading (+0), 
middle (+1) and trailing (+2) strands in order of decreasing C-terminal overhang, as first defined by 
Emsley et al37. The triple-helix is stabilized by periodic hydrogen bonds between the amide-nitrogen of 
glycine residues and the amide-oxygen of residues in position Xaa on the strand with -1 stagger. The 
estimated contribution of each hydrogen bond to the Gibbs free energy of trimerization is between -1.4 
to -1.8 kcal17. 
The observed tight packing of the triple-helix explains the necessity for the staggered assembly of α-
chains as well as the strict requirement for glycine residues in every third position: the side-chains of 
residues in these positions are oriented such that any amino acid other than glycine would experience 
steric clashes with the neighbouring strand with +1 stagger.  
Structural Aspects of Triple-helix Stability 
The collagen triple helix is not stable at body-temperature38, which is rather surprising considering its 
significance as a structural element in the extracellular matrix. This meta-stability underlines that 
collagens, although often being regarded merely as rigid scaffolding proteins, are remarkably dynamic 
and able to utilize their structural “imperfections” for biological activity. Transient structural 
perturbations in the collagen triple-helix are indeed essential for many processes such as recognition of 
collagens by matrix metalloproteases (MMPs) or the binding of heparin to the collagenous domain of 
acetylcholinesterase, determining its anchoring location39.  
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Although the interaction interface of triple-helix forming PPII helices is dominated by the polypeptide 
backbone, triple-helix stability is greatly influenced by α-chain sequence. As is often the case with 
polymeric molecules, the loss of conformational entropy upon adopting an ordered structure is 
significant for collagen α-chains. This underlies the fact that the stability is intrinsically governed by 
the propensity of α-chains to pre-organize and adopt a PPII helical conformation, and further of the PPII 
helices to intertwine to form a triple-helix.  
The strict requirement for glycine residues at every third position, as explained above based on the 
crystal structure, is also showcased by the fact that many diseases, such osteogenesis imperfecta (OI) 
or epidermolysis bullosa, are linked to substitutions of these key residues in collagen α-chains40,41. 
While the disruptive impact of such mutations on triple-helix stability is also influenced by the identity 
of adjacent amino acids and is for instance attenuated in proline-rich regions42, they can also have more 
indirect effects: during collagen biosynthesis, re-nucleation of the triple helix beyond interruptions 
induced by glycine substitutions occurs after a certain delay, during which the collagen α-chains are 
overmodified. Such overmodifications alter triple-helix as well as fibril stability and can be detected in 
patients suffering from OI induced by such glycine substitutions43. This is further substantiated by the 
observation that glycine mutations closer to the C-terminus are causative to more severe forms of OI: 
triple-helix formation proceeds from the C- towards the N-terminus (see 1.1.4), and thus a larger 
proportion of the molecule is exposed to overmodification during the presumably identical delay44. 
The influence of amino acids in positions Xaa and Yaa on triple-helix stability has been thoroughly 
characterized in the past. Fortunately, natural collagens only contain relatively few of the theoretically 
possible different triplets (more than 400), which somewhat limited the effort to map the triple-helix 
formation propensities of amino acids. The effect of amino acid substitutions on thermal stability is 
usually assessed using host-guest peptides. These consist of a variable region (guest), which is flanked 
N- and C- terminally by trimeric regions of (GPP)n or (GPO)n triplets (host). The Tm of peptides is 
commonly determined using circular dichroism spectropolarimetry, a valuable tool for distinguishing 
between and quantifying monomeric and triple-helical content. Persikov et al.45 have studied 
substitutions at either the Xaa or the Yaa site and made the following observations:  
 
(i) Charged residues generally show the least destabilizing effect at either position. This 
might indicate the presence of polar interactions of the sidechains with neighbouring 
α-chains. Arginine, for instance, is capable of forming a hydrogen bond with the 
backbone-carbonyl of an adjacent chain, stabilizing the triple helix46. 
(ii) Glycine and hydrophobic residues show the largest destabilizing effect at either 
position. This is most probably due to the conformational restrictions imposed by the 
PPII helix geometry in case of the former, which enjoys access to a large area in φ, ψ-
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space; the hydrophobic residues, on the other hand, are possibly too bulky and block 
solvent access to the backbone of neighbouring strands.  
(iii) The enthalpic contributions (ΔH°) of Pro (in position Xaa) as well as Hyp (in position 
Yaa) to triple-helix formation were noted to be among the lowest of all amino acids, 
supporting the idea that entropic aspects and preorganization are critical to triple-helix 
stability. This was further corroborated by the medium correlation observed between 
the propensities of PPII helix and triple-helix formation. 
(iv) Disregarding GPP and GPO, the most stable triplets were GEO and GPR for 
substitutions at position Xaa and Yaa, respectively. Complementary studies where both 
positions were substituted simultaneously have identified GER as the most stable triplet 
lacking Pro and Hyp, which concurs with the above findings. It was furthermore 
observed that triplet stability correlates positively with its occurrence in natural 
collagen.47 
 
Proline hydroxylation is known to exert profound influence on the stability of collagens, and the 
incidence of proline hydroxylation in different organisms clearly correlates with the average 
environmental temperature these experience48. The influence of hydroxylation on thermal stability is 
dependent on location and stereochemistry: the vast majority of hydroxyprolines are typically found in 
the Yaa position and with (2S,4R) configuration, with exceptions being very rare (collagen type IV 
incorporates (2S,3R)-hydroxyproline in both positions)49,50. Due to the supercoiling of the PPII helices, 
residues in positions Xaa and Yaa become distinguishable in terms of solvent exposed area as well as 
preferred main-chain dihedral angles. Experimentally determined36 φ, ψ and ω values for proline 
residues in Xaa or Yaa position of a triple helical α-chain are contrasted with those of an ideal PPII 
helix in table 1.1. These differences, especially in φ, lead to a position dependent discrimination against 
different pyrrazolidine pucker conformations of proline and derivative residues. The dihedral angles of 
the Xaa position favour the Cγ-endo (also called “down”) pucker, which is slightly preferred in prolines, 
while in the Yaa position the Cγ-exo (“up”) pucker is preferred, which is the predominant form in 
hydroxyprolines due to the gauche effect of the electron withdrawing hydroxyl group (Fig 1.2)51,52. The 
gauche effect describes the tendency of molecules to adopt a conformation with a dihedral angle of ± 
60° between vicinal polar bonds, which in case of hydroxyproline allows for a larger overlap between  
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Table 1.1 │ Comparison of backbone dihedral angles between the PPII helix and the collagen triple-helix. 
 φ / ° ψ / ° ω / ° 
Xaa (Triple-helix) -74.5 164.3 176.0 
Yaa (Triple-helix) -60.1 152.4 175.4 
Xaa (PPII-helix) -75 145 180 
Yaa (PPII-helix) -75 145 180 
  
the Cδ-H σ and Cγ-O σ* orbitals and thus leads to increased stabilization via hyperconjugation. Studies 
with a range of proline derivatives have supported the view that hydroxylation influences stability 
primarily via this stereoelectronic effect, and that the participation of the hydroxyl-group in H2O 
networks, long believed to be the major contributor to stability, is secondary to this53,54,55. 
 
Figure 1.2 │Gauche effect and preferred pucker conformation in 4S-hydroxyproline. The Newman 
projection (proximal atom: Cγ, distal atom: Cδ) of hydroxyproline conformers is shown in the top. The gauche 
effect, in this case attributable to hyperconjugation between the Cδ-H σ and Cγ-O σ* orbitals, leads to a preference 
of the Cγ-exo pucker over the Cγ-endo pucker, despite increased steric clash of the 4-hydroxyl group with the 
vicinal amide group. The Cγ-exo pucker corresponding to this conformation is thus favored in 4S-hydroxyproline. 
 
 
One requirement for the formation of the collagen triple-helix is an all-trans configuration of α-chain 
peptide bonds. Proline residues, though, induce a high population of cis-configuration in peptide bonds 
with N-terminally preceding amino acids. This is primarily due to the steric clash between Cα of the N-
terminally adjacent amino acid and Cδ of proline in trans-configuration, increasing its energy state to 
become similar to that of the cis-configuration. The incorporation of hydroxyproline, however, affects 
both the thermodynamics and kinetics of the cis-trans isomerisation: it shifts the ratio towards the trans-
configuration due to the large n→π* overlap seen in the Cγ-exo pucker56 and increases the isomerization 
rate via weakening of the neighboring amide resonance57. 
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1.1.4 Collagen Biosynthesis  
Like all classical secretory proteins, procollagen α-chains are co-translationally translocated into the 
lumen of the rough ER. The nascent polypeptide chains are immediately subjected to a range of post-
translational modifications and interactions with molecular chaperones, which orchestrate the proper 
processing, folding and trafficking of the maturing collagens. As is evident from the deleterious impact 
of α-chain overmodification on the stability and downstream processing of collagens, the regulation of 
the trimerization of unfolded chains is crucial, since the tightly packed triple-helix renders the α-chains 
inert towards further enzymatic modification. One consistent observation with collagen modifying 
enzymes is that they often have a secondary chaperone function. This is a sensible solution considering 
the sheer abundancy and size of the intrinsically meta-stable and aggregation-prone collagens. Many 
collagen modifying enzymes are not exclusive to collagens; furthermore, they often act as part of 
heterocomplexes with more than one function. While the complex P3H1/CRTAP/CypB, for instance, 
is responsible for (3S) hydroxylation of prolines (vide infra), defects in any member of the complex not 
only abolish hydroxylation but also lead to a general overmodification of collagens, suggesting that it 
fulfils a range of chaperoning roles that are not yet fully understood58. One proposed function of this 
complex is to transiently stabilize junctions between triple-helical and unfolded regions until other 
chaperones such as HSP47 can take over59. Lysine hydroxylases similarly act as member of a 
multifunctional complex together with FK506-binding protein 65 (FKBP65), 78kDa Glucose-regulated 
protein (GRP78, or BiP) and HSP47 (vide infra)60, suggesting a complex interplay between the proteins.  
Hydroxylation 
The three isoforms of proline-4-hydroxylase (P4H) catalyse the oxidation of proline to (2S,4R)-
hydroxyproline. The enzyme acts as part of a heterotetramer, in which two molecules P4H associate 
with two molecules of protein disulphide isomerase (PDI). The latter is not involved in the 
hydroxylation, but is required for the solubility and ER retention of P4H61. The catalysed reaction is 
stereospecific and occurs at the Yaa position of Gly-Xaa-Yaa triplets; it requires Fe2+ as cofactor and 
O2 as well as α-ketoglutarate as cosubstrates. The latter is oxidatively decarboxylated to yield succinate 
and CO2. Ascorbate, while not involved in proline hydroxylation per se, is required as a reducing agent 
for the regeneration of Fe2+. P4H also seems to act as a chaperone, since it can still associate with 
hydroxylated α-chains, albeit at a lower affinity than with its natural substrate62. 
Proline-3-hydroxylases catalyse the oxidation of proline residues in Gly-Pro-Hyp sequences to (2S,3S)-
hydroxyproline. P3H forms a heterotrimer with cartilage-associated protein (CRTAP), which shares 
homology with P3H but lacks the monooxygenase domain, and the peptidyl-prolyl cis-trans isomerase 
cyclophilin B (CypB)59. 
Lysine hydroxylases are luminally oriented, peripheral membrane proteins which catalyse the 
hydroxylation of lysine residues in Gly-Xaa-Lys sequences. 5-hydroxylysine is a pre-requisite for O-
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glycosylation and fiber-crosslinking during later stages of collagen maturation63. The active enzyme, 
which requires the same cofactor and cosubstrates as P4H and P3H, is a homodimer which forms with 
the aid of the peptidyl-prolyl cis-trans isomerase FKBP6564. Latest research has suggested that GRP78 
and HSP47 are also involved in the chaperone complex, with the former, an ER homologue of HSP70, 
acting as a scaffold for the complex and the latter acting as a negative regulator for lysine 
hydroxylation60,65. Lysine hydroxylation occurs both throughout the collagenous domain (catalysed by 
LH1) as well as telopeptide domains (LH2), and its extent varies strongly between different collagen 
types and tissues63. 
Glycosylation 
A number of hydroxylysine residues are further modified via O-glycosylation. This involves the 
glycosyltransferases GLT25D1 and GLT25D2, which catalyse the attachment of β-galactose, and LH3, 
which (primarily) catalyses the attachment of α-glucose58. The biological significance of these O-linked 
sugars has not been fully elucidated yet; one study indicates that they are, among other roles, involved 
in recognition by the endocytic collagen receptor uPARAP/Endo18066. 
Collagens are also subjected to N-glycosylation with mannose-rich oligosachharides in their telopeptide 
domains67. The consensus sequence for recognition by ER-resident glycosyltransferases in collagens, 
Asn-Ile-Thr, is highly conserved within fibrillar collagens; collagens lacking N-glycosylation, however, 
surprisingly do not show any abnormalities in assembly, secretion or deposition68. The discovery that 
endocytosis of cleaved collagen type I C-propeptides occurs via the mannose-receptor69 renders it likely 
that N-glycolysation is utilized in recognition and clearance of cleaved proopeptides. 
Cis-trans isomerization 
The isomerization of cis peptide bonds to trans, which is the rate limiting step in triple-helix formation70, 
is catalysed by the peptidyl-prolyl cis-trans isomerases (PPI) CypB, FKBP22 and FKBP6558. CypB is 
believed to be the major catalyst in triple-helix formation; in addition to the above mentioned complex 
with P3H and CRTAP it also interacts with other collagen modifying enzymes and chaperones such as 
PDI, Calnexin/Calreticulin, LH1 and HSP4758. Data on the role of FKBP22 is scarce, but it has been 
reported to be involved in the processing of collagens type III, VI and X71. In addition to its cis-trans 
isomerase activity, FKBP65 also displays properties of a chaperone, since it can bind unfolded as well 
as triple-helical collagen72; furthermore, it is a positive regulator for lysyl hydroxylation73,74. 
Folding of collagens 
Chain selection, trimerization and proper registration of fibrillar collagens is steered by their C-terminal 
propeptides. The folding of these propeptides is aided by rER-residing general chaperones such as 
GRP78, PDI, Calnexin/Calreticulin and CypB58; furthermore, these domains undergo enzymatic 
modifications such as LH2 catalysed lysine hydroxylation and PDI catalysed formation of intra- and 
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interchain disulphide bonds. Although this covalent cross-linking stabilizes tertiary structure of the 
subunits and prevents dissociation of the trimer, it has been shown that collagen type IV mutants lacking 
critical cysteine residues are still capable of producing mature collagen75. It thus seems plausible that 
the disulphide bridges rather serve to impose structure than stabilize it. Besides its thiol-shuffling 
function, PDI also serves as a chaperone and associates to nascent collagen α-chains, preventing 
aggregation and improper trimerization62. The C-propeptides are believed to be closely associated to 
the rER membrane, facilitating trimerization due to the higher probability of a trimolecular binding 
event in two-dimensional space76. Upon assembly of three C-terminal propeptides, triple-helix 
formation is initiated by prolyl-4-hydroxylation in at least two Gly-Xaa-Pro triplet repeats localized at 
the C-terminal end of the collagenous domain77, and proceeds towards the N-terminus in what is often 
called a zipper-like fashion78.  
It should be mentioned that this folding process is not uniform for all collagens: in the ectodomains of 
membrane collagens type XIII and XVII, for example, trimerization proceeds in the opposite direction7; 
furthermore, in FACIT collagen type IX, the NC2 domain was identified as being responsible for chain 
selection and trimerization of neighboring collagenous domains79.  
Trafficking, processing and secretion 
Collagens are very large proteins with a length often exceeding 300 nm, while vesicles budding from 
the ER membrane typically have a diameter of 60 - 80 nm. The transport of procollagen from the rER 
to the Golgi apparatus thus requires special vesicles shaped to accommodate rigid, rod-like cargo of 
such size. These large vesicles share the coat-protein Complex 2 (COPII) coat associated with ER 
anterograde transport vesicles, but the principles governing their formation and cargo selection are not 
fully understood. The ubiquitin ligase CUL3-KLHL12 has been reported promote assembly of large 
vesicles via monoubiquitinylation of SEC31, a component of the outer COPII coat80. Loading of the 
cargo vesicle with collagen is mediated by transmembrane protein transport and Golgi organization 
protein 1 (TANGO1), an ER exit-site residing protein operating in complex with cutaneous T-cell 
lymphoma-associated antigen 5 (cTAGE5). TANGO1 interacts with the COPII inner coat components 
Sec23A and Sec24C, and furthermore with the guanine nucleotide-exchange factor Sec12, thus possibly 
modulating the Sar1 GTPase cycle which initiates vesicle formation81,82. In this way TANGO1 
resembles Sedlin, another protein associated with secretion of large proteins, which also acts via 
regulation of nucleotide exchange in Sar1. Recent experiments have revealed that the SH3-domain of 
TANGO1 barely recognizes collagens on its own and that the binding is mediated by HSP4783. The 
importance of TANGO1 for collagen shuttling is corroborated by experiments in which knockout of 
TANGO1 in chondrocytes, fibroblasts, endothelial and mural cells was observed to hamper secretion 
of collagen types I, II, III, IV, VII and IX84.  
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In the early stages of the secretory pathway (ERGIC and Golgi apparatus), gradually decreasing pH 
induces full dissociation of HSP47 from procollagen, while members of the “a disintegrin and 
metalloproteinase with thrombospondin motifs” (ADAMTS) family of proteases cleave off the N-
terminal prodomains. The truncated procollagen is then transported to the extracellular space via large 
Golgi-to-plasma membrane carriers (GPCs) which originate from the trans-Golgi85. During this transit, 
the C-terminal prodomains are removed by members of the tolloid family of metalloproteinases such 
as bone morphogenic protein 1 (BMP1) or tolloid-like 1 (TLL1) to yield tropocollagen consisting only 
of a collagenous domain86. This results in a marked decrease in solubility (up to five orders of 
magnitude) and promotes lateral aggregation and assembly into fibrils87. While it is understood that 
fibrillogenesis is initiated by the removal of the C-propeptides, there is uncertainty concerning the exact 
location of it. In the Kadler model of fibrillogenesis, tropocollagen generation and its subsequent lateral 
association takes place in GPCs, while in the Birk model these steps occur extracellularly in a cavernous 
invagination of the plasma membrane87. Fibrillogenesis is nucleated by collagens V and XI88, regulated 
by small leucine-rich proteoglycans (SLRPs) such as decorin, biglycan, lumican or fibromodulin87 and 
aided by adaptor proteins such as the TSPN family member cartilage oligomeric matrix protein 
(COMP). Assembly of tropocollagen typically occurs in a staggered, head-to-tail fashion, the former 
resulting in the characteristic banded pattern seen in collagen fibrils89. The fibrils are stabilized by intra- 
as well as inter-molecular crosslinking between allysine and/or hydroxyallysine residues, generated by 
lysyl oxidases (LOXs) via oxidative deamination of specific lysine and hydroxylysine residues, 
respectively. Lateral and longitudinal growth leads to formation of mature collagen fibers, which in turn 
also form increasingly complex structures such as parallel bundles or basket waves90. 
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Figure 1.3│Schematic overview of collagen biosynthesis. The assembly of a prototypical fibrillar collagen 
molecule is depicted up to fibril formation. Post-translational processing is grouped into 14 chronologically 
arranged steps which are indicated by yellow circles. An overview of these steps and the involved enzymes and 
chaperones is provided in the legend. 
 
Step 
 
Description 
 
Associated Proteins / Complexes 
1 Proline hydroxylation [P3H1/CRTAP/CypB], [P4H/PDI] 
2 Lysine hydroxylation [LH2/FKBP65/GRP74/HSP47] 
3 Peptidyl-prolyl cis-trans isomerisation CypB, FKBP22, FKBP65 
4 Glycosylation GLT25D1, GLT25D2, LH3 
5 Folding of C-Propeptide and disulphide bond formation PDI, GRP78, Calnexin, Calreticulin, CypB 
6 Triple-helix formation and progression - 
7 HSP47 binding to triple-helix - 
8 Folding of N-Propeptide PDI, GRP78, Calnexin, Calreticulin, CypB 
9 Packaging and anterograde transport to Golgi body [TANGO1/cTAGE/Sec12/Sec23A/Sec24C], HSP47 
10 HSP47 dissociation - 
11 N-Propeptide cleavage ADAMTS 
12 Retrograde transport of HSP47 KDEL-receptors 
13 C-Propeptide cleavage BMP1, TLL1 
14 Fibril formation and crosslinking SLRPs, Comp, LOXs 
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1.2 Heat Shock Protein 47 
1.2.1 An Introduction to HSP47 
Heat-shock protein 47 (HSP47, also known as Colligin or CBP1) is an ER-residing molecular chaperone 
exclusive to procollagen*. The glycoprotein is a member of the Serine-Protease Inhibitor (Serpin) 
family (Clade H, member 1), albeit a rather superficial one, since unlike the majority of its paralogues 
it is not secreted, lacks inhibitory activity against proteases and does not undergo Serpin-typical 
conformational transitions. Untypical for chaperones, HSP47 is substrate-specific and recognizes the 
already folded conformation of its substrate, i.e. triple-helical collagen; client binding and release is 
furthermore not coupled to nucleotide exchange or hydrolysis. HSP47 is also unique in that it is the 
only heat-shock inducible protein in the ER, all other chaperones operating in context of other forms of 
ER-stress stimuli.  
 
HSP47 is an essential component of the finely tuned collagen biosynthesis machinery. Knockdown of 
HSP47 is lethal: HSP47-/- mice display grievous phenotypes such as ruptured blood vessels, defective 
basement membranes and aberrancies in the orientation of epithelial tissues. These deficiencies result 
in severe growth retardation and are lethal 11.5 days post-coitus91. The loss of the chaperone precipitates 
as various abnormalities in collagen biosynthesis, ranging from the accumulation and aggregation of 
overmodified and improperly processed collagens (mainly of type I) in the ER to the complete absence 
of some collagens (type IV), while the integrity of collagen type III was intriguingly found to be intact 
although it is a known substrate. The importance of HSP47 is also manifested by the implication of the 
protein in various collagen-related diseases: destabilizing missense mutations (Leu78Pro in humans, 
Leu326Pro in dachshund), for instance, result in severe forms of osteogenesis imperfecta92,93. 
Upregulation of HSP47, on the other hand, is commonly linked with diseases characterized by increased 
collagen deposition, such as arteriosclerosis, myocardial infarction or fibrosis94,95.  
 
HSP47 can be found in ancient vertebrate classes such as Sarcopterygii and Actinopterygii, and given 
its central role in collagen biosynthesis, it is presumably common to all vertebrates. Constitutive 
expression of HSP47 is only observed in collagen producing cells such as fibroblasts, myoblasts or 
adipocytes. Expression levels are tightly correlated to that of collagens, with up- or down-regulation of 
the latter being mirrored by HSP4796, and curiously respond to changes in gravity: while the expression 
is stimulated by hypergravity, it is attenuated under microgravity conditions97.  
 
 
*The client-repertoire of HSP47 is not fully explored; currently, direct evidence for HSP47 binding is available 
in form of SPR experiments for collagens I through V98. Unpublished data (PhD Thesis Anna Köhler, research 
group Prof..Zaucke) is available which indicates HSP47 also recognizes other non-fibrillar collagens besides 
collagen IV. 
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1.2.2 Serpins and Structure of HSP47 
The superfamily of Serpins is perhaps better defined by structure than function, since contrary to what 
their name suggests not all Serpins are inhibitors of serine proteases. Some Serpins are able to inactivate 
Cys-proteases (SerpinB9 is an inhibitor of Caspase-199) or show cross-class inhibition (Endopin 2A100), 
and quite a number are not inhibitory at all, as is the case with the collagen chaperone HSP47 or the 
storage protein Ovalbumin. Serpins have been found in all branches of life, partaking in diverse 
functions ranging from host defence in insects (Serpin27A)101 to blood coagulation102. Although the 
size of serpins varies considerably (from 292 amino acids in case of the viral Serpin Cytokine Response 
Modifier 1 (CRM1) to 478 amino acids in case of C1-Inhibitor), and the pairwise identity of their amino 
acid sequence can be as low as 25%103, they all share a structurally conserved core domain consisting 
of seven to nine α-helices, three β-sheets and a flexible, solvent exposed loop called the reactive center 
loop (RCL). These typical structure formed by these elements constitutes the so-called Serpin-fold. 
The Serpin-typical structural elements are highlighted in figure 1.4 using the structure of HSP47. The 
largest of the β-sheets (βA) consists of five strands aligned with the long axis of the protein. All 
structural elements lie to one side of the plane formed by βA (“inner side”), the sole exception being 
hF, which in HSP47 is tethered to the “outer side” of βA via a salt-bridge between Asp182, located at 
its C-terminal end, and Lys129, located at the N-terminal end of s2A. In inhibitory Serpins, this salt 
bridge is absent since the inhibitory mechanism requires transient dislocation of hF to make room for 
the baited protease (vide infra)104.  The longest two strands of β-sheet A, s3A and s5A, are noteworthy 
in that they are aligned in parallel. This creates a natural weak point in the β-sheet which can be 
mitigated via insertion of a new, anti-parallel strand. This feature lies at the heart of Serpin-typical 
conformational transitions involving the insertion of the RCL (or a part of it) as s4A. 
β-sheets B and C form the bulk of the C-terminal part of Serpins. The latter comprises the greatest part 
of the collagen-binding interface of HSP47 (see 1.2.4) and is also utilized by other Serpins for 
interaction with effector molecules; one example would be the binding of Protein Z by Protein Z-
dependent Inhibitor, a Serpin involved in the coagulation cascade105. In the majority of ligand-
dependent Serpins, binding of glycosaminoglycan cofactors occurs near or at α-helix D, inducing large 
conformational re-arrangements relayed by the cluster of α-helices surrounding hD. Protein C inhibitor 
(PCI), as one of the exceptions, binds heparin and heparan sulfate using α-helix H106.  
The RCL is a flexible loop protruding from the protein core in the native Serpin fold. It is tethered to 
s5A via its N-terminus and to s1C via its C-terminus. The key feature of the RCL (at least in an 
overwhelming majority of Serpins) is its capacity to insert itself in between the parallel β-strands s3A 
and s5A as an additional, anti-parallel strand s4A. There are many variants of RCL insertion: partial or 
full, intramolecular or intermolecular, spontaneous insertion of the intact loop or insertion triggered via  
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Figure 1.4│Structural elements of HSP47. (Left) HSP47 displays a typical Serpin fold consisting of 9 α-helices 
(hA - hI, blue), 3 β-sheets (βA: magenta, βB: green, βC: yellow) and the reactive center loop (red, missing 
structural elements are represented by the dotted line). (Right) Amino acid clusters regulating insertion of the 
reactive center loop into βA in Serpins. (PDB ID: 4AU3) 
 
proteolytic cleavage within the RCL. The conformer resulting from RCL insertion is 
thermodynamically much more stable, as evidenced by the large increase in its thermal stability. This 
has the interesting implication that the native Serpin fold, called the stressed state (S), is intrinsically 
metastable and capable of spontaneous transition to the relaxed state (R). While the additional anti-
parallel β-strand is certainly the most important factor in driving the S → R transition, the native state 
also displays several non-ideal interactions such as side-chain overpacking, burial of polar groups in 
hydrophobic pockets, or cavities in the latter107. Four clusters of amino acids exert influence over the 
dynamics of RCL insertion: the breach cluster, consisting of the C-termini of s3A and s5A, as well as 
the shutter region, consisting of the middle part of βA together with s1B and the N-terminal part of hB, 
regulate the propensity of s3A and s5A to move apart and allow insertion of the RCL. The hinge region 
of the RCL is critical for the flexibility of the loop, and in some cases capable of partial insertion into 
βA. Lastly, the gate region, consisting of a short loop between s4C and s5C, regulates the S → R 
transition in uncleaved Serpins, since the RCL has to swing its C-terminus around this cluster for full 
insertion. This also requires dissolution of s1C.  
Proteolytic cleavage within the RCL frees its C-terminus, greatly increasing the probability and speed 
of insertion. This is exploited by inhibitory serpins, which present a bait site close to the C-terminal end 
of the RCL; upon proteolytic cleavage, the insertion of the freed RCL proceeds fast enough to compete 
with the final step of proteolysis, the nucleophilic attack of H2O on the acyl-enzyme intermediate. The 
A B 
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protease is dragged along the outer side of βA and translocated to the opposite end of the serpin. This 
occurs before the protease is able to release its substrate via hydrolysis; in the resulting complex, 
distortion of the active site renders it fully inoperable108. 
1.2.3 HSP47 in Collagen Biosynthesis 
After initial trimerization of procollagen C-prodomains, aided and stabilized by disulphide bond 
formation, proline hydroxylation initiates formation of the triple helix. As the folding progresses 
towards the N-terminus, multiple molecules of HSP47 are recruited to the  triple helical regions, 
showing a slight preference towards more N-terminal sequences109. They accompany their client during 
TANGO1-mediated loading into elongated, COPII-coated vesicles and into the Golgi-body. 
Experiments in which various stages of Golgi-transport were inhibited have indicated that client release 
occurs either in the ER - Golgi Intermediary Compartment (ERGIC) or in the cis-Golgi110. Complex 
dissociation is presumed to be induced by the mildly acidic environment (pH in Golgi body = 6.2111) in 
these compartments. This presumption is further substantiated by the behaviour of HSP47 in gelatin-
affinity chromatography, where elution is observed to occur at a pH of 6.3112. After dissociation, 
retrograde transport of HSP47 to the ER via KDEL receptors occurs113, while procollagen further 
continues down the secretory pathway. 
The principal functions of HSP47 in collagen biosynthesis are:  
(i) Stabilization of the triple helix (i.e. prevention of unwinding). Although it has 
previously been reported that HSP47 binding did not alter the thermal stability of 
collagens type I and III115, it should be noted that the experiment did not account for 
the temperature dependency of the HSP47 - collagen interaction; the fact that the 
HSP47 - collagen interface encompasses all three strands strongly suggests that the 
triple-helical conformation is indeed stabilized.  
(ii) Regulation of post-translational modification, which is accomplished on one hand via 
prevention of local unwinding of the triple-helix, thus denying collagen modifying 
enzymes access to the single stranded substrate (indirect regulation), and on the other 
hand via direct binding and modulation of such enzymes. The negative regulatory 
effect of HSP47 on proline-4 hydroxylation is an example of indirect regulation114, 
while a case of regulation via direct interaction has been described above for lysine 
hydroxylases.  
(iii) Marking the collagen as ready for ER-export and serving as a universal collagen-
adaptor molecule for TANGO1. 
Another role often attributed to HSP47 is the obstruction of premature lateral aggregation of 
procollagen. While this property of HSP47 is evident from the concentration and pH-dependent 
inhibition of collagen fibril formation observed in-vitro116, it is somewhat at odds with the fact that a 
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prerequisite for fibril formation is the removal of the C-propeptides, a process which occurs in post-
Golgi compartments while HSP47 already is fully dissociated in the cis-Golgi.  
1.2.4 Molecular details of the HSP47 - Collagen Interaction 
Although it was earlier reported that HSP47 is capable of binding both single-chain and triple-helical 
procollagen110, latest evidence indicates that only the latter is recognized117. An arginine in the Yaa 
position of any single α-chain constitutes the primary binding motif for HSP47118, and the interaction 
can be further compounded by an additional threonine in position Yaa-1* on the same strand119. In 
addition to these primary binding sites, HSP47 was also shown to interact with CMPs consisting purely 
of (Gly-Pro-Pro) triplets, albeit very weakly120. In the same study it was also noted that successive 
incorporation of (2S-4R)-Hydroxyproline in position Yaa gradually decreases the strength of the 
interaction. HSP47 recognition of collagens requires the latter to consist of a minimum of five triplets118. 
Interestingly, crosslinking experiments indicate the presence of an alternative binding mode in which 
the long axis of HSP47 is oriented parallel to the helical axis of collagens121. It is not clear whether this 
mode of interaction has any biological significance; however, it can be hypothesized that this 
presumably transient association is utilized by HSP47 to scan the collagen triple-helix for its preferred 
binding motif Gly-Pro-Arg, or to migrate in direction of the N-terminus as the triple-helix extends. 
Widmer et al. have previously succeeded in co-crystallizing Canis lupus HSP47 with various CMPs 
and solving the structure via X-Ray diffractometry (Fig. 1.5)122. The crystal structure was in satisfactory 
agreement with previous findings and has shed light on the molecular details of the HSP47 - collagen 
interaction. The binding interface spans roughly five triplets on the collagen side, which allows for a 
sufficient twist of the triple-helix for HSP47 to recognize all three α-chains. The interaction has 
predominantly hydrophobic character; polar interactions are limited to a salt bridge between Asp385 in 
HSP47 and Arg (arbitrarily assigned position Yaa0) of the CMP, accounting for the binding motif of 
HSP47, and hydrogen bonding between Arg222 of HSP47 and the backbone carbonyl of Proline in 
position Yaa-1 (Fig. 1.6). The stabilizing contribution of Thr in position Yaa-1 stems from the formation 
of a small H-bond network involving Ala303, Ile304, Ser305 and a water molecule (Fig. 1.6). The 
largest part of the interaction interface is provided by β-sheet C. While the RCL is positioned such that 
it could possibly contribute to binding of the CMP, crystal structures reveal that it is highly mobile and 
does not adopt any fixed position or conformation for interaction with the CMP. The crystal structure 
shows two molecules of HSP47 bound to one molecule of CMP, each recognizing an arginine residue 
in the leading and trailing strand, respectively. The long axis of one HSP47 molecule is rotated close to 
170° around the CMP helical axis in relation to the other, resulting in a near head-to-head orientation. 
There are no evident interactions between the HSP47 molecules; it can be assumed that the previously  
*Yaa-1 indicates the residue in the triplet preceding the arginine, which is defined as Yaa0. 
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Figure 1.5│Crystal structure of clHSP47 in complex with a collagen model peptide. The CMP spanning 18 
triplets is oriented such that the N-terminus points to the top in the upper panel. The leading, middle and trailing 
strands are colored white, grey and black, respectively. The homotrimeric CMP can accommodate two molecules 
of HSP47, which recognize an arginine in the leading (blue) and trailing strand (wheat), respectively. [PDB ID: 
3ZHA]. 
 
reported cooperativity in binding115 stems from the HSP47 induced stabilization of triple-helical 
collagen, which in turn increases the probability of further HSP47 binding. 
 
90° 
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1.3 Thesis Aims 
The work presented in this thesis revolves around the interaction between the collagen chaperone 
HSP47 and its client.  Two independent aims will be pursued: 
(i) Understanding the molecular details of pH-dependent client-release, and 
(ii) Identifying small organic molecule inhibitors of the interaction.    
Molecular details of the pH-dependent client-release 
It has been long postulated that the mildly acidic environment in the Golgi drives dissociation of HSP47 
from procollagen. The pH-shift experienced by the complex occurs close to the pKa value of the 
imidazole side-chain of histidine residues (approximately 6.0, but variable depending on the 
microenvironment; values ranging from 5.4 to 7.6 have been experimentally determined123), suggesting 
that the protonation of key histidines might trigger client-release. The first part of this work will focus 
Figure 1.6│Molecular details of the 
HSP47 - Collagen interaction. (Left) 
Client-binding of HSP47 is mediated 
by extensive hydrophobic contacts 
involving the indicated residues 
(wheat, blue). Polar interactions 
(green dashed lines) encompass R222 
and D385 (green). R222 acts as a H-
donor to the backbone carbonyl on 
residue Yaa-1, in this case T8, while 
D385 forms a salt-bridge with the 
arginine in position Yaa0 (R11).   
(Top) Threonine residues located at 
position Yaa-1 on the same strand as 
the recognized arginine stabilize the 
interaction via a H2O (red spheres) 
mediated H-bond network (green 
dashed lines) involving the backbone 
carbonyl oxygen of A303 and I304 as 
well as the side chain of S305. [PDB 
ID: 3ZHA] 
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on validating this hypothesis, identifying the histidine(s) responsible for complex dissociation and 
understanding the underlying mechanism. This will encompass assessing the impact of histidine 
mutants* on pH-dependent client-release via interaction studies. These will be supplemented with in-
silico analysis based on the crystal structure of clHSP47, conducted by Eileen Socher (Research Group 
Prof. Dr. Sticht, Universität zu Erlangen) in context of a collaborative effort. Furthermore, structural 
aspects of client-release will be investigated, with the main effort lying on obtaining a low-pH crystal 
structure of HSP47.  
Identifying small organic molecule inhibitors of the HSP47 - collagen interaction 
Collagens, being an essential component of the extracellular matrix, are indispensable for the 
development and homeostasis of tissues and ultimately for the well-being of vertebrates. In humans, 
aberrant collagen biosynthesis is implicated in a multitude of pathologic conditions, which, due to the 
ubiquity of collagens often lead to severe diseases that can be lethal.  Fibrosis alone, i.e. the excessive 
deposition of fibrous ECM components, contributes to approximately 45% of mortalities in developed 
countries124. In light of this, HSP47 as a crucial component in collagen biosynthesis has great potential 
as a therapeutic drug target. The second part of this work will thus focus on developing a high-
throughput compatible assay for monitoring HSP47 - collagen complex formation and its application 
in interrogating a medium-sized (approximately 40,000 compounds) library with the aim of identifying 
at least one lead structure for small-molecule inhibitors of the HSP47 - collagen complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*In the context of this work, the term “histidine mutant” refers to the substitution of a histidine, as opposed to 
substitution with one 
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2. Material and Methods 
2.1 Material 
2.1.1 Chemicals 
Common laboratory chemicals were purchased from AppliChem, Carl-Roth, Hampton Research, 
Merck KGaA, Promega, Serva, Sigma-Aldrich and Thermo Scientific. 
2.1.2 Proteins 
Table 2.1 │ Enyzmes 
 
Class Enzyme Supplier 
Restriction endonucleases DpnI, NdeI, NheI, PstI, SmaI, XbaI, XhoI New England Biolabs 
DNA Polymerases Pfu DNA Polymerase 
Q5 High Fidelity DNA Polymerase 
Own production 
New England Biolabs 
DNA Ligases T4 DNA Ligase 
QuickLigase 
Roche 
New England Biolabs 
Proteinases Porcine Pancreas Elastase I Sigma-Aldrich 
 
Table 2.2 │ Antibody and Protein Conjugates 
 
Class Conjugate Supplier 
HTRF Reporter αGST-mAb-Eu3+ - Cryptate 
αGST-mAb-Lumi4-Tb3+ - Cryptate 
Streptavidin - XL665 
Cisbio 
Cisbio 
Cisbio 
HRP-coupled Reporter Streptavidin - HRP 
α-His6 mAb - HRP 
 
Thermo Scientific 
Thermo Scientific 
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2.1.3 Buffers and Media 
 
Table 2.3 │ Buffers and Media 
*DTT was included only for the purification of HSP47 constructs 
 Buffer/Medium Composition 
Common Buffers PBS 2mM KH2PO4, 8mM Na2HPO4 (pH 7.4), 2.7mM 
KCl, 137mM NaCl 
 HBS 20mM HEPES (pH 7.5), 150 mM NaCl 
 TBS 50mM Tris ∙ HCl (pH 7.5), 150mM NaCl 
 TBS-T TBS, 0.05% (v/v) Tween-20 
 McIlvaine Buffer 0.1M Citric acid, 0.2M Na2HPO4 (Composition 
defined by cross-titration to yield desired pH)
 
 TAE 40mM Tris ∙ HCl (pH 7.6), 20mM Acetic acid, 
1mM EDTA 
Protein Purification Lysis Buffer TBS, 0.2mM PMSF, 1mM EDTA, 4mM DTT* 
 High-salt Wash Buffer 50mM Tris ∙ HCl (pH 7.5), 500mM NaCl, 4mM 
DTT* 
 Size Exclusion Chromato-
graphy Buffer 
 
HBS, 2mM DTT* 
SDS-PAGE Running Buffer 25mM Tris, 192mM Glycine, 1%(w/v) SDS 
 Sample Buffer (6 x) 375mM Tris ∙ HCl (pH 6.8), 12% (v/v) β-
mercaptoethanol, 60% (v/v) Glycerol, 0.06% (v/v) 
bromphenolblue 
 Staining Solution 20% (v/v) Ethanol, 10% (v/v) Acetic acid. 0.04% 
(w/v) Coomassie Brilliant Blue G-250 
 Destaining Solution 20% (v/v) Ethanol, 10% (v/v) Acetic acid 
Immunoblotting Transfer Buffer 25 mM Tris ∙ HCl (pH 8.3), 192 mM Glycine, 10% 
(v/v) Methanol 
 Developing Buffer 100mM Tris ∙ HCl (pH 8.6), 0.2mM p-Coumaric 
acid, 1.25mM Luminol, 0.009% (v/v) H2O2 
HTRF Standard Assay Buffer HBS, 0.01% (v/v) Tween-20, 0.1% (w/v) BSA 
Agarose Gel 
Electrophoresis 
Running Buffer 40mM Tris ∙ HCl (pH 8.6), 20mM Acetate, 1mM 
EDTA 
Cell Culture LB-Medium 1% (w/v) Tryptone, 0.5% (w/v) Yeast Extract, % 
(w/v) NaCl (pH 7.5) 
 LB-Agar LB-Medium, 1.5% (w/v) Agar 
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2.1.4 Synthetic Peptides 
Peptides for use in crystallization experiments were purchased from BioMatik. 
2.1.5 Synthetic DNA Oligonucleotides  
Primers for PCR-reactions were purchased from Eurofins in “Salt-free” purity and are listed in the 
appendix (Table A.1). 
2.1.6 E. coli Strains 
Table 2.4 │ E.coli Strains 
Strain Genotype Supplier 
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-
1 gyrA96 relA1 
Invitrogen 
BL21(DE3) F–ompT hsdSB(rB–, mB–) gal dcm (DE3) Invitrogen 
 
2.1.7 Software 
Table 2.5 │ Software 
Name Application Supplier 
ACD/Chemsketch Chemical structures ACD/Labs 
CLC Workbench DNA, RNA & protein sequence analysis Qiagen 
Excel Data processing Microsoft 
OriginPro Data processing, graphical representation Origin Labs 
Powerpoint Figures Microsoft 
PyMol Protein structure visualization Schrödinger LLC 
Word Text editing Microsoft 
 
 
2.2 Nucleic Acid Methods 
2.2.1 Isolation & Purification of DNA 
The plasmid DNA of interest was amplified in-vivo in E. coli DH5α cells and isolated using the QIAprep 
Spin Miniprep kit (Qiagen) according to instructions of the manufacturer. The procedure combines a 
modified version of the alkaline extraction procedure developed by Birnboim & Doly with DNA 
purification via adsorption on silica in presence of chaotropic salts.  
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A 5 ml ON culture of cells was pelleted and resuspended in 200 µl hypotonic resuspension buffer 
supplemented with RNAse A.  Lysis was initiated via addition of 200 µl NaOH and SDS containing 
lysis buffer and terminated within 5 min by addition of 350 µl KOAc containing neutralization buffer. 
The lysate was centrifuged for 2 min at 10,000 g and the clear supernatant transferred to a silica spin-
column. After centrifugation for 1 min at 10,000 g, the column was washed with 700 µl 70% Ethanol 
and the DNA eluted with 50 µl ddH2O. After quantification, DNA samples were stored at -20 °C. 
2.2.2 Spectrometric Determination of DNA concentration 
Since both purine and pyrimidine nucleobases absorb light in the UV range (λmax ranging from 252 nm 
for pdG to 271 nm for pdC in physiological buffer)125, the concentration of a DNA solution can be 
calculated using the Lambert - Beer law after photometric measurement of A260nm. For precise 
calculations it should be taken into account that the extinction coefficient varies for each nucleobase, 
between RNA and DNA, and between single-stranded and double-stranded DNA; for the purposes of 
this thesis, though, the simplified formula [DNA] = A260nm ·  50 µg/ml was sufficient. Measurements 
were performed with a NanoDrop (Thermo Scientific) microvolume spectrophotometer. 
2.2.3 Agarose Gel Electrophoresis  
This method is routinely used for resolving DNA mixtures of varying size. Nucleic acids, being 
polyanions, can be subjected to electrophoresis in a gel consisting of a three-dimensional mesh of 
polymer, in this case the oligosaccharide agarose, and buffer solution. Since the charge/mass ratio of 
DNA and thus the drift velocity is constant independent of size, separation is achieved solely due to 
increased retention of larger fragments (or less compact forms of plasmid DNA) by the polymeric 
matrix. The resolving range is determined by the composition of the gel: 1% (w/v) agarose gels can 
efficiently separate DNA fragments of sizes ranging from 500 bp up to 10,000 bp. For visualization of 
the DNA, dyes such as ethidium bromide or SYBR Safe are used; these compounds show a strongly 
increased fluorescence upon intercalation into DNA. 
Gels were prepared by dissolving the appropriate amount of agarose in boiling TAE buffer. After 
cooling down to around 50 °C, SYBR Safe DNA Gel Stain was added according to the supplier’s 
protocol and the solution was cast and left to gelate. DNA samples were mixed with loading dye and 
loaded onto gels submerged in TAE buffer. Electrophoresis was conducted with a constant voltage of 
90 V. The indicator dye bromophenol blue, contained in the loading dye, runs parallel to DNA 
fragments of approximately 450 bp length and was monitored for timely termination of electrophoresis. 
The DNA was finally visualized by placing the gel on a 300 nm UV-transilluminator and the size 
determined via comparison with a reference DNA ladder. 
For the extraction of DNA from preparative agarose gels, the DNA bands were cut out, the gel melted 
at 65 °C and the DNA retained and washed on silica spin-columns as described under 2.2.1. 
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2.2.4 Polymerase Chain Reaction & Site-directed Mutagenesis 
The polymerase chain reaction, first reported 1968 by Kleppe & Khorana and further developed by 
Kary Mullis in 1983, is a staple technique in molecular biology for the in-vitro amplification of DNA. 
Heat-stable DNA-polymerases from thermophilic organisms are employed to catalyse template guided 
DNA-synthesis in a cycled reaction. The reaction takes place in alkaline buffer supplied with Mg2+ ions, 
dNTPs and a pair of short (optimally 18 - 22 bp long) oligomers, called primers in analogy to their 
cellular RNA counterparts. Primers are required by the DNA-polymerase to initiate DNA elongation.  
They can be designed such that they frame the DNA sequence to be amplified by annealing at the 5’ 
end of the sense (forward primer) as well as the anti-sense strand (reverse primer), respectively.  
The PCR cycles between:  
(i) Denaturation of double-strand DNA at 95 °C,  
(ii) Annealing of the primers at a temperature dependent on their G/C content and the 
position of these, and  
(iii) Extension of the primers in the 3’ direction at the optimum temperature of the employed 
DNA-polymerase.  
Starting from the second cycle, the region flanked by the primers is amplified exponentially each round. 
After selective DpnI digest of the Dam-methylated template DNA, the amplified DNA fragment can be 
purified via silica spin-columns. 
In site-directed mutagenesis, the desired change in DNA sequence is introduced with the primers. Using 
primers which overlap leads to the amplification of the whole template DNA in a PCR. After DpnI 
digest of template DNA, the newly synthesized, linear DNA is circularized via ligation using the T4 
ligase and transformed into E. coli DH5α cells (see next section). The mutagenic primers were designed 
according to an optimized protocol126. The composition of a standard PCR mixture is summarized in 
table 2.6; table 2.7 shows the parameters of a typical PCR cycle.   
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Table 2.6 │ Composition of PCR Mixtures  
 
Component Volume / µl 
10 x Reaction Buffer 2.5 
10mM dNTP Mix 2.5 
10µM Fw Primer 1 
10µM Rv Primer 1 
50ng/µl Template DNA 1 
Pfu DNA Polymerase 1 
ddH2O 16 
 
 
Table 2.7 │ Parameters of PCR Cycling 
 
 
2.2.5 Restriction Endonuclease Digestion of DNA & Ligation 
DNA Fragments which are amplified via PCR can be inserted into an expression vector using bacterial 
restriction endonucleases and concomitant ligation. The vector is commonly linearized with two 
endonucleases that create so-called cohesive ends with short single-strand overhangs. After digestion 
with the same pair of enzymes, the fragment can be ligated into the vector in the correct orientation. If 
necessary, restriction sites compatible with those present in the expression vector are introduced to the 
fragment as a 5’ extension of the primers.  
Template and fragment DNA were incubated for 1 h at 37 °C with the desired endonucleases in the 
buffer recommended by the manufacturer. After purification via agarose gel electrophoresis, the 
digested template and fragment DNA were mixed in a stoichiometric ratio of at least 1:3. 9 µl of the 
DNA mixture were supplemented with 1 µl of the provided 10x buffer and incubated for 2 h at RT 
following the addition of 0.5 µl T4 ligase. The ligated DNA was finally transformed into competent E. 
coli DH5α cells for amplification (Section 2.3.2). 
Phase T / °C t / s Cycles 
Initial Denaturation 95 30 1 
Denaturation 
Annealing 
Elongation 
95 
50 - 65 
72 
30 
30 
120 / kbp 
 
30 
Final Extension 72 180 1 
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2.2.6 DNA Sequencing 
Named after its developer Fred Sanger, this method of identifying DNA sequences is based on in-vitro 
amplification of the DNA of interest in presence of dideoxynucleotide triphosphates (ddNTPs) that are 
conjugated to fluorophores with nucleobase-specific emission wavelengths. Incorporation of ddNTPs 
leads to termination of the replication process due to the lack of the 3’-OH group; after several cycles 
of the PCR, this chain-termination will have occurred statistically at every single position of the 
template sequence. This produces fragments of every possible length, with the identity of the 3’- 
terminal nucleobase being encoded in the fluorophore. The mixture is resolved using capillary 
electrophoresis, and the sequence assembled via assigning the corresponding nucleobase to fragment 
size. 
Sanger sequencing was performed by GATC Biotech (Konstanz, Germany). 
 
2.3 Cell Culture Methods 
2.3.1 Transformation of DNA 
Heat-shock transformation of E. coli with plasmid DNA is achieved via subjecting the cells to a rapid 
change in temperature from 0 °C to 42 °C and back to 0 °C. Although the exact mechanism is largely 
obscure, it has been proposed the heat-pulse initially leads to the release of lipids into the extracellular 
space, resulting in a decrease of membrane potential as well as in membrane fluidity. The restoration 
of the latter to normal values after the cold-pulse leads to a further release of lipids from the membrane. 
This induces formation of transient pores and allows the uptake of DNA, which is facilitated by the 
decreased membrane potential as well127. The heat-shock transformation competency of cells is usually 
enhanced via prior incubation with ice-cold CaCl2128. The inclusion of an antibiotic resistance gene on 
the expression vector allows the selection of transformed clones. 
E. coli DH5α cells were treated with an ice-cold 0.1 M CaCl2 solution for 20 min and stored at -80 °C. 
For DNA transformation, small aliquots were thawed on ice, 50 ng of plasmid DNA added and the 
mixture incubated for at least 20 min. Heat-shock was induced via heating the cell suspension to 42 °C 
for 2 min and subsequent cooling on ice for 30 min. The cells were transferred to fresh LB medium and 
allowed to recover at 37°C for at least 30 min, after which they were spread on LB-agar plates with the 
appropriate antibiotic (Ampicillin: 100mg/l, Kanamycin: 50mg/l). 
2.3.2 Protein Expression in E. coli 
Protein expression was conducted in E. coli BL21 (DE3) cells using the T7 RNA polymerase/promoter 
system established by Tabor et al.129. T7 RNA polymerase displays exceptionally high specificity 
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towards its promoter and low rates of transcription termination, ensuring overexpression of the desired 
protein by the cell. The genes for both the polymerase and the protein of interest are under control of 
the lac operon and as such are inducible via addition of IPTG.  
A single colony was picked from a selection plate and transferred to 50 ml sterile LB medium 
supplemented with the appropriate antibiotic. The cell suspension was kept overnight at 37 °C in 
Erlenmeyer flasks under constant shaking with 180-200 rpm to ensure proper gas exchange and to 
prevent sedimentation. The ON culture was diluted 1:20 with antibiotic supplemented LB, and 
cultivated to an optical density of A600nm = 0.6 - 0.8 (for expression times up to 5 h) or 1.0 - 1.2 (for 
overnight expression) and equilibrated to the desired temperature. Protein expression was induced via 
addition of 0.1 - 1 mM IPTG. The cells were harvested after the optimal expression time by 
centrifugation for 20 min at 4,000 g in a chilled centrifuge. The cells were then re-suspended and washed 
with PBS, after which they were pelleted and stored at -20 °C. In case of Hsp47, flasks without chicanes 
were discovered to give a better yield. 
2.3.3 Cell lysis 
Cell lysis was achieved using sonication. Ultrasonic waves traversing through a liquid medium induce 
the formation and growth of small vapour cavities. The rapid collapse of these in a process called 
cavitation generates a liquid jet and shock waves that lead to extreme local temperatures (up to 5000 K) 
and pressures of (up to 1000 atm). The dissipation of this energy is utilized to rupture cellular 
membranes. 
The cell pellets were thawed on ice, re-suspended in lysis buffer to yield a 5% (w/v) suspension and 
sonicated on ice in portions of 40 ml using a 50 ml Falcon tube. The sonotrode was immersed ca. 1-2 
cm into the cell suspension and a 2 s pulse, followed by a 2 s cooling pause, was applied at 40% 
amplitude for a total of 15 min pulse time. Cell debris and aggregates were removed via centrifugation 
at 4 °C for 20 min with a minimum of 50,000 g. 
 
2.4 Protein Biochemistry Methods 
2.4.1 Chromatographic Methods 
Initial enrichment of the protein of interest from crude cell lysate was achieved using affinity 
chromatography. The common feature of this ensemble of protein purification methods is the 
immobilization of the target protein on a resin, which allows for easy washing away of contaminants 
using batch or continuous flow techniques. The solid phase is functionalized with moieties capable of 
binding genetically encoded “tags” fused to the protein of interest. These tags can be whole proteins or 
short amino acid chains and are usually added as N- or C- terminal extensions separated via short linker 
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regions from the core protein. In this work, immobilized metal affinity chromatography (IMAC), 
glutathione affinity chromatograpy and the Strep-tactin/Strep-tag system were used.  
In its most widespread form, IMAC is based on the chelation of immobilized Ni2+ or Co2+ cations via 
polyhistidine tags consisting of 5 - 10 neighboring histidines. Commonly, cross-linked beaded agarose 
(Sepharose) functionalized with the chelators nitrilotriacetic acid (NTA) or iminodiacetic acid (IDA) 
serves as the solid phase. Binding of the protein of interest occurs via formation of a coordination 
complex between the metal ions and imidazole sidechains via either one of their nitrogen atoms. Elution 
of the protein of interest can be achieved via displacement with high concentrations of imidazole or 
decreasing pH.  
Glutathione affinity chromatography exploits the high affinity enzyme-substrate binding reaction 
between the 26 kDa protein Glutathione-S-Transferase (GST) and its natural substrate, reduced 
glutathione. The latter is covalently attached to a solid phase via its sulfhydryl moiety and can be used 
to immobilize target proteins carrying a GST fusion tag. Elution of the protein of interest is achieved 
through displacement with an excess of reduced glutathione. Besides serving as an affinity tag, the 
highly soluble and rapidly folding GST is also commonly utilized to increase the expression yield of 
target proteins. 
The Strep-tag system is based on an eight amino-acid affinity peptide which binds selectively to 
streptavidin. The affinity tag was initially discovered from a genetic random library and binds reversibly 
at the same site as (D)-biotin, the natural ligand of Streptavidin130. The commercially available system 
has been further optimized and utilizes Streptactin, an engineered version of Streptavidin, and the 
Strep[II]-tag WSHPQFEK131. Elution of the bound protein is achieved via displacement with an excess 
of (D)-desthiobiotin. 
In a further polishing step, the eluate from the affinity chromatography can be subjected to size 
exclusion chromatography. In size exclusion chromatography, a mixture of proteins is passed through 
a matrix consisting of microbeads with pores of variable size. The resin usually consists of cross-linked 
dextran (Sephadex). Proteins are resolved according to their hydrodynamic radius and shape, with larger 
proteins eluting earlier since they are restricted from diffusing into smaller pores. This method is a 
useful complement to affinity chromatography, since aggregates and other contaminants are removed; 
furthermore, it serves to remove the eluting agent without the need for dialysis or other buffer exchange 
methods. 
Ni-NTA Affinity Chromatography: The crude cell lysate was supplemented with 10 mM Imidazole and 
passed over 1 - 5 ml pre-equilibrated Ni-NTA Sepharose resin with an approximate rate of 1 ml/min. 
The resin was washed with at least 10 column volumes (CV) TBS containing 50 mM Imidazole and 10 
CV high-salt wash buffer. Elution was performed with 1-2 CV TBS containing 250 mM Imidazole. 
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Glutathione Affinity Chromatography: The crude cell lysate was passed over 5 ml pre-equilibrated 
Glutathione Sepharose. The resin was washed with at least 10 CV TBS and 10 CV high-salt wash buffer. 
The protein of interest was eluted with 1-2 CV TBS pH 8.0 supplemented with 10 mM reduced 
glutathione. 
Strep-tactin Affinity Chromatography: The crude cell lysate was passed over 1-5 ml pre-equilibrated 
Strep-tactin resin. The resin was washed with at least 10 CV TBS followed by 10 CV high-salt wash 
buffer and the protein eluted with 1-2 CV TBS containing 2.5 mM (D)-desthiobiotin.  
Size-exclusion Chromatography: The eluate from the affinity chromatography was concentrated up to 
a maximal volume of 2 ml using ultrafiltration units with the corresponding MWCO. The sample was 
then resolved in Superdex S200 packed 16/60 columns using the AEKTA Purifier chromatograpy 
system and a flow-rate of 1 ml/min. 
2.4.2 SDS-PAGE 
In this staple technique developed by Laemmli in 1970, proteins are denatured in presence of the anionic 
surfactant sodium dodecylsulfate (SDS) as well as the reducing agent β-mercaptoethanol, and separated 
according to their electrophoretic mobility µ in a polyacrylamide gel. The initial denaturation step 
produces unstructured, linear peptide chains with a practically uniform negative charge-to-mass ratio 
resulting from the bound SDS. This serves to negate the influence of protein shape, flexibility and net 
charge on µ, resulting in a strict dependence of sample retention on protein mass.  In discontinuous 
SDS-PAGE, samples are focused into a thin band using isotachophoresis prior to their separation. This 
occurs in the stacking gel, which has a less dense polymer mesh and a lower pH (pH 6.8) compared to 
the resolving gel (pH 8.8). Upon application of an electric field, highly mobile Cl- anions present in the 
gel quickly form a front of leading electrolyte (LE). The efflux of charge from the gel is compensated 
by glycinate ions moving into the stacking gel from the running buffer (pH 8.3); these are protonated 
to yield zwitterionic glycine, which forms a front of trailing electrolyte (TE) due to its low 
electrophoretic mobility. The zone between the LE and TE fronts, called the Kohlrausch discontinuity, 
is characterized by a steep gradient in electric potential stemming from excess counter-ions left behind 
by the LE. This causes the TE front to migrate at the same speed as the LE front. Proteins with µ values 
in between those for chlorine and glycine are stacked into thin layers between the ion boundaries as the 
double front passes through. Upon entering the resolving gel, deprotonation of glycine leads to a 
collapse of the Kohlrausch discontinuity and standard electrophoretic resolution occurs. The protein is 
fixed in the gel with an acetic acid and ethanol containing solution and traditionally stained with the 
protein binding dye Coomassie Brilliant Blue (CBB) R-250 or its colloidal form, CBB G-250. A faster 
method for visualizing the protein involves an UV-light induced reaction of tryptophan residues with 
2,2,2-trichloroethanol (TCE). This results in the formylation of the indole side-chain, generating a 
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species which fluoresces in the visible light range and thus can be easily detected using a 300 nm-
transilluminator132. 
SDS-polyacrylamide gels were prepared from the mixtures summarized in table 2.8. Polymerisation 
was initialized via addition of the catalyst tetramethylethylenediamine (TEMED) and the free radical 
initiator ammonium persulfate (APS) as the last two components. The gels were cast using a gel-casting 
set from Bio-Rad.  
Table 2.8 │ Composition of SDS-Polyacrylamide Gels 
 Volume per Gel / ml  
 12% Resolving Gel 16% Resolving Gel Stacking Gel 
30% (v/v) Acrylamide / Bis-acrylamide 1.80 2.40 0.42 
3M Tris ∙ HCl (pH 8.8) 0.75 0.75 - 
1M Tris ∙ HCl (pH 6.8) - - 0.32 
10% (w/v) SDS 0.05 0.05 0.05 
10% (w/v) APS 0.068 0.068 0.05 
TEMED 0.003 0.003 0.003 
TCE 0.05 0.05 - 
H2O 1.91 1.31 1.75 
 
2.4.3 Western Blotting & Immunodetection 
Western blotting involves separation, immobilization and subsequent detection of specific proteins 
using antibodies coupled to conjugated reporter enzymes. The protein of interest is electrophoretically 
transferred to a hydrophobic membrane (polyvinylidene difluoride (PVDF) or nitrocellulose) and 
recognized by monoclonal antibodies that are directed against common affinity tags or the protein itself. 
This is followed by addition of a secondary (polyclonal) antibody (directed against the primary 
antibody) which is conjugated to the reporter enzyme, after which the complex can be visualized via 
the coupled color-reaction. In this work, signal enhancement using the secondary antibody was omitted 
via utilization of α-His6 mAb - HRP or Strep-tactin - HRP. For the detection of protein bands, enhanced 
chemiluminescence (ECL) was used. ECL involves HRP catalysed oxidation of luminol by H2O2, 
yielding 3-aminophtalate in an excited electronic state. Decay of the latter is coupled to the emission of 
a photon and can thus be quantified. 
Protein mixtures resolved via SDS-PAGE were transferred via electrophoresis to either a Nitrocellulose 
membrane or a PVDP membrane pre-treated with methanol. In this work, the “wet-blot” method was 
utilized, which requires complete submersion of gel and membrane in transfer buffer (TAE buffer). 
Blotting was conducted for 1 h at 8 °C with a current of 1.5 mA per cm2 membrane. The membrane 
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was then blocked for 1 h with 1% (w/v) milk powder and incubated for 1 h with the appropriate 
antibody, after which the bands were visualized according to a standard ECL protocol133. 
2.4.4 Biotinylation of Proteins 
The selective reaction of primary amines by NHS-activated esters was exploited for chemical coupling 
of biotin to lysine side-chains and the N-terminus of proteins134 (It should be noted that the selectivity 
of this reaction is debated, and acylation of Ser, Thr, Tyr, and even Arg side chains via commonly 
employed amine reactive esters is reported in literature135).  
1 mg protein in 1 ml HBS was supplemented with 20 eq NHS-Biotin (Thermo Scientific) from a 20 
mM DMSO stock. The Eppendorf tube was vigorously shaken at RT for 30 min, after which the reaction 
was quenched via addition of 100 mM TRIS. Excess biotin was removed via dialysis or SEC. 
2.4.5 Spectrometric Determination of Protein concentration 
The concentration of protein samples was determined via measurement of the transmission at λ = 280 
nm using a NanoDrop (Thermo Scientific) microvolume spectrophotometer. At this wavelength, the 
aromatic side-chains of tryptophan and tyrosine residues absorb strongly, with extinction coefficients 
close to 5,500 M-1cm-1 and 1,490 M-1cm-1, respectively136. Disulphide bonds contribute weakly to the 
absorption (ε280nm = 125 M-1cm-1)136, but have to be taken into account when using buffers with 
dithiothreitol (DTT) as an additive. The extinction coefficients of the used protein constructs were 
calculated from the sequence using the online tool http://web.expasy.org/protparam.  
Since the synthetic CMPs used in this work did not contain any aromatic residues, their concentration 
was determined via quantification of the peptide bond absorption at λ = 214 nm. The extinction 
coefficients of the peptides were calculated from available literature values137.
 
2.4.6 Colorimetric Protein Assays 
Protein concentration determination via measurement of A280nm was supplemented with colorimetric 
assays. In these, protein concentration is reported either through proportional association of an 
environment-sensitive dye to the protein, changing its spectral properties, or through generation of an 
intermediate species which reacts further to yield a UV-VIS detectable species. The color development 
is quantified and correlated to protein concentration using a calibration curve prepared with known 
concentrations of a standard protein, usually bovine serum albumin (BSA). 
The Bradford assay is based on the dye Coomassie Brilliant Blue, which experiences a large red-shift 
of its absorption spectrum (λ = 465 nm to 595 nm) upon deprotonation. The anionic form is stabilized 
upon binding of the dye to basic and hydrophobic side chains of proteins and thus can be utilized to 
quantify the amount of protein. In the BCA-Assay, Cu2+ is reduced to Cu1+ by the protein peptide bonds; 
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the monovalent cation is then complexed by two molecules of bicinchoninic acid, forming a complex 
strongly absorbing at λ = 562 nm. 
2.4.7 Differential Scanning Fluorimetry 
This thermal shift assay exploits the change in fluorescence intensity of an environment-sensitive 
reporter dye upon binding of to the hydrophobic core of proteins exposed by thermal denaturation. The 
variant used in this work utilizes the dye SYPRO Orange, which can also be used to stain protein gels 
with a much higher sensitivity than Coomassie dyes138. The binding of SYPRO Orange to proteins 
occurs non-specifically to hydrophobic patches on proteins. Since the fluorescence of the dye is 
effectively quenched by water, recruitment to hydrophobic patches and the associated shielding of the 
fluorophore from the solvent leads to an increase in its quantum yield. The exposure of the hydrophobic 
core of thermally denatured proteins can thus be detected by a rather sharp increase in SYPRO Orange 
emission intensity at temperatures nearing the Tm. 
White 96-Well PCR plates (BioRad) were loaded with 45 µl protein solution diluted in the desired 
buffer to a final concentration of 0.1 - 0.2 mg/ml. After addition of 5 µl SYPRO Orange from a 10x 
stock solution, the plate was sealed with a transparent adhesive seal, briefly spun down and placed in a 
CFX96 real-time PCR Machine (BioRad). Starting from 20 °C, the block was heated at a rate of 1 
°C/min and the fluorescence intensity (excitation: 492 nm, emission: 516 nm) recorded in 5 s intervals. 
The Tm was deduced from a plot of intensity against temperature as the inflection point of the slope. 
2.4.8 Circular Dichroism Spectroscopy 
The differential absorption of left- and right-circular polarized light by optically active chiral molecules, 
called circular dichroism and quantified using ellipticity (θ), is a method commonly employed to 
investigate higher-order structures of chiral macromolecules such as DNA and proteins. Circular 
polarised light is obtained via passing linear polarized light through a birefringent crystal at an angle of 
45°. This splits the light into two equal, perpendicular electric field vectors, one of which is retarded 
due to the birefringent character of the crystal. Using so called quarter-wave plates, this phase shift can 
be adjusted to equal λ/4, resulting in a helical progression of the resulting electric field vector and thus 
yielding circular polarisation. For studying protein secondary structure, both far UV spectra (180 nm to 
240 nm) as well as near UV spectra (> 250 nm) can be recorded. The former involve π → π* and n → 
π* transitions in the peptide bond, which absorb around wavelengths of 190 nm and 210 nm, 
respectively. Since transition dipole moments of chiral molecules in an ordered structure influence each 
other (e.g. via exciton coupling), each secondary structure has a characteristic fingerprint and the far 
UV spectrum provides information about secondary structure element content in the protein. The near 
UV spectrum primarily involves absorption by the aromatic sidechains of tryptophan, tyrosine and to a 
lesser extent phenylalanine, as well as disulphide bonds. These elements are typically interspersed in 
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the protein and contribute independently to the spectrum, making near UV CD-spectroscopy suitable 
rather for detection of changes in the tertiary structure than deduction of it. 
The protein was dialyzed extensively against phosphate buffer pH 7.0 and diluted to a final 
concentration of 0.1 mg/ml in phosphate buffer with the desired pH. The sample was transferred to a 1 
mm quartz cuvette and spectra were recorded at 20 °C with a Jasco J-715 spectropolarimeter. Instrument 
parameters were set to a bandwidth of 2 nm, a response of 2 s and a sensitivity of 100 mdeg. The CD-
spectra were averaged from 10 accumulations recorded with a data pitch of 0.2nm and a scan speed of 
50 nm/min each. 
2.4.9 Isothermal Titration Calorimetry 
This calorimetric technique is a valuable tool to study biomolecular interactions, revealing the enthalpy 
(ΔH), entropy (ΔS), affinity (KD) and stoichiometry of binding in a single experiment using unmodified 
sample. In a typical ITC experiment, the ligand is titrated into a thermally insulated sample cell 
containing the interaction partner. The heat released or taken up by the binding is quantified via the 
difference in electric heating power required to reach temperature equilibrium between the sample cell 
and a reference cell. Binding isotherms are shown using the Wiseman plot, in which the change in heat 
per mol injectant is plotted against the molar ratio of the interaction partners. 
HSP47 and the CMP were extensively dialysed against the same buffer and calibrated to a concentration 
of 300 µM and 30 µM, respectively. 70 µl of HSP47 solution were transferred to the syringe unit of a 
GE Healthcare MicroCal ITC200 calorimeter, while the sample cell was filled with 350 µl of the CMP 
solution. The cell temperature was equilibrated to the desired temperature and the reference power set 
to 10 µcal/s. The stirring speed was adjusted to 800 rpm and a total of 40 injections of 2.5 µl over 2.5 s 
were recorded with a spacing of 150 s. 
2.4.10 Dynamic Light Scattering 
Also known as quasi-elastic light scattering, DLS allows the determination of the size distribution in 
solutions or suspensions of small particles. The scattering of monochromatic light by small particles (in 
context of this work, proteins) in solution leads to an arbitrary pattern of constructive and deconstructive 
interference (speckle pattern) on a small detection area. As the particles undergo Brownian motion, the 
interference pattern shifts, and the detected intensities of the spots on the speckle pattern fluctuate. 
These are sampled after short intervals of time and the spot intensities analysed using the intensity auto-
correlation function, with smaller particles showing a fast decorrelation due to the higher velocity of 
random motion. 
100 µl of protein sample were retrieved directly after SEC and centrifuged for 10 min at 10,000 g to 
remove aggregates and contaminant particles. The solution was then transferred into UVettes 
(Eppendorf) and the measurements conducted using a DynaPro NanoStar (Wyatt) instrument with a 
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laser wavelength of 658 nm. For determination of the polydispersity, five measurements with 10 
acquisitions each were averaged.  
2.4.11 Biolayer Interferometry 
Biolayer interferometry (BLI) is a relatively new optical method which, similar to the more widely 
known surface plasmon resonance spectroscopy, is used in interaction studies to determine the affinity 
and kinetic parameters of binding reactions. Using either chemical ligation or one of the commonly 
used tags such as the His6- or Myc-tag, one of the interaction partners is immobilized on an appropriately 
functionalized biosensor. The biosensor is then dipped into a solution of the other binding partner and 
white light passed through. Reflection of the light occuring at an internal reference layer as well as at 
the periphery of the biolayer leads to an interference pattern which is subject to change as the optical 
density of the biolayer is altered due to association/dissociation events.  
Experiments were performed with streptavidin coated SA- or SAX-biosensors using the BLItz System 
(Pall ForteBio). The sensors were loaded with 10 µM CMP-R18-biotin to a maximal response of 
approximately 5 nm, and free streptavidin binding sites were blocked with 10 µM biocytin. HSP47 (C-
Strep) was diluted at least 1:10 into the desired McIlvaine buffer to yield a final concentration of 5 µM. 
The set time parameters were: 10 s baseline, 60 s association, 80 - 140 s dissociation and 10 - 40 s 
regeneration. All sensorgrams were recorded in triplicate and the measurements performed in blocks of 
1 to 3 mutants per day, with wild type HSP47 being included in each block as a reference. The kinetic 
parameters kon and koff were extracted through non-linear curve fitting using the following equations for 
the association (Eq. 1) and dissociation (Eq. 2) phases: 
 
The KD was subsequently calculated from the ratio of the kinetic parameters (KD = koff / kon). 
2.4.12 Fluorescence Spectroscopy & Homogenous Time-Resolved FRET 
Förster Resonance Energy Transfer (FRET) 
The transfer of energy between chromophores via dipole-dipole coupling, FRET, has found many uses 
in biochemistry as a tool to study molecular interactions and dynamics. Virtually all applications exploit 
the strong dependency of FRET-efficiency on the distance between the chromophores. The efficiency 
(Eq. 1) 
(Eq. 2) 
   R = Response, [A] = Analyte concentration, t = Time 
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is inversely proportional to the 6th power of the distance, which, depending on chromophore properties, 
translates into a practical effective range of up to 10 nm. This order of magnitude covers the diameter 
of most proteins (the minimum radius of a 500 kDa globular protein has been calculated to be 5.21 
nm139), making FRET ideally suited to study protein interactions or conformational rearrangements. 
Homogeneous Time-resolved FRET 
The HTRF technology extends the basic FRET technique via incorporation of time-resolved 
fluorimetry. The basic premise is the inclusion of a FRET-donor with a long emission half-life, allowing 
a delayed read-out, typically after 50-150 µs. This has the advantages of:  
(i) Bypassing short-lived fluorescence originating from buffer components, biomolecules 
or small organic molecules, and  
(ii) Providing an internal standard via quantifying the ratio of acceptor fluorescence and 
residual donor fluorescence.  
A key component of the HTRF technique are trivalent lanthanide cations. Two properties render them 
ideally suited for employment as a FRET-donor: they display a large stokes-shift and possess long 
excited-state lifetimes in the order of miliseconds. Since lanthanide cations have very small absorption 
cross-sections (i.e. the probability of an absorption process), their utilization in fluorescence based 
experiments requires photosensitization via coordination to an organic chromophore, called an 
“antenna”, which typically has a high extinction coefficient and the capacity to transfer energy to the 
metal ion140. This is commonly achieved via insertion of the lanthanide ion as the guest cation into 
cryptands. As a FRET-acceptor with compatible excitation and emission properties, a modified 
phycobilliprotein pigment from red algae, XL665, is used. 
Assay Establishment 
The reporters αGST-mAb-Lumi4®-Tb3+-Cryptate and Streptavidin-XL665 were purchased from 
Cisbio as lyophilized powder, dissolved in ultrapure water, aliquoted and stored at -80 °C and -20 °C, 
respectively. Prior to the experiment, the reporters were thawed for at least 20 min on ice, diluted with 
standard assay buffer to yield a 4x solution based on the manufacturer’s recommended final 
concentration. The resulting solutions were then mixed 1:1 to yield the 2x reporter mixture. The analyte 
proteins were thawed in hand, diluted with standard assay buffer to yield a 4x solution of the desired 
concentration and kept at RT. 
For the assay, 10 µl of the reporter mixture were dispensed into a white, low-volume, flat-bottom 384-
well plate (Greiner) and starting with HSP47, 5 µl of each analyte solution were added to yield a final 
volume of 20 µl per well. The plate was covered airtight with aluminium foil and incubated for 1 h at 
RT. In displacement assays, 0.4 µl of a 5x stock solution of the inhibitor were added directly after 
HSP47 and the plate was incubated for 15 - 60 min before the biotinylated CMP was added. The plate 
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was read out using a Synergy H4 plate-reader (BioTek) with the following components installed: 
excitation filter (330/80), emission filter 1 (620/10), emission filter 2 (665/8), dichroic mirror (400 nm 
cut-off). The optics position was set to top 400 nm and the read height to 7.0 mm. Prior to the 
measurement, the gain was scaled to a value of 50,000 for the well with the highest fluorescence 
intensity. Emission intensities at 620 nm and 665 nm were recorded with a 500 µs delay after excitation 
at 340 nm. 
Statistical evaluation of assay robustness 
The Z-factor is a screening window coefficient which is commonly utilized to assess the reliability and 
robustness of an assay141. The parameters taken into account are the signal dynamic range, i.e. the 
window between the mean values for positive and negative controls, as well as the variability within 
the data itself. The Z-factor is defined as: 
 
 
 
 
 
While the Z-factor reflects the quality of an already conducted HTS assay, the closely related Z’-factor 
only takes into account the control data and thus quantifies the intrinsic reliability of the assay system 
without interference by compounds (Eq. 4). 
 
 
 
 
 
A Z-factor of 1 describes an ideal assay, while Z-factors larger than 0.5 are deemed excellent. 
The Hook-Effect 
The Hook effect, which is often observed in immunoassays, describes a phenomenon in which a too 
large analyte concentration leads to a decrease in signal and thus a false negative result. In context of 
the HTRF-assay, this occurs due to excess analyte saturating each reporter type separately, reducing the 
(Eq. 3) 
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population of signal generating species (i.e. analyte molecules which have recruited one molecule of 
each reporter type). 
2.4.13 Protein Crystallization 
Supersaturated solutions are thermodynamically unstable systems. Minimization of the free energy of 
the system drives the aggregation and removal of excess solute as a solid, which can either be in form 
of amorphous precipitate or in form of crystals. This principle underlies the strategies to obtain proteins 
in crystalline form, which is the pre-requisite for X-ray crystallographic structure determination. 
Achieving supersaturation is commonly aided by additives such as salts, polymers or organic solvents. 
These crystallants act via modulating the physicochemical properties of the bulk solvent, for instance 
decreasing the solvation capacity, exerting volume exclusion effects or altering the dielectric constant, 
and can also promote protein - protein interactions. Other critical factors are the pH of the solution, 
which influences the protein itself, and temperature, which directly affects the solubility. 
In this work, the vapor diffusion technique was utilized for protein crystallization. The protein solution 
is mixed with precipitant solution, typically in a volumetric ratio of around 1:1, and the drop sealed 
airtight together with a reservoir of the latter. Due to the difference in precipitant concentration between 
drop and reservoir, water will diffuse from the former into vapor phase, gradually leading to 
supersaturation of the protein solution and, if the conditions have been chosen right, to crystal nucleation 
and growth. Since it is nigh impossible to predict which protein will crystallize under which conditions, 
obtaining protein crystals usually involves screening against a variety of conditions. 
Crystallization of HSP47 was performed according to the protocol established by Widmer et al122. For 
initial screening purposes, the protein at a concentration of 20 - 24 mg/ml was transferred to 96-Well 
sitting drop iQ plates (TTP labtech) and mixed with precipitant solution in ratios of 1:1, 1:2 and 2:1 
using a Mosquito pipetting robot (TTP labtech) to yield a total drop volume of 300 nl. For conditions 
that yielded crystals, the drop volume was up-scaled to 2 µl using CombiClover Junior plates (Jena 
biosciences). The reservoir volumes were set at 70 µl for TTP plates and 300 µl for Clover plates. The 
plates were sealed airtight, stored at 20 °C and regularly inspected for crystal growth. 
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3. Results 
3.1 Protein Production and Characterization 
3.1.1 Proteins and Peptides used in this Work 
HSP47 Constructs 
The HSP47 constructs used in this work are all based on Canis lupus familiaris HSP47, encompassing 
residues L36 through L418. The residue numbering as it appears in this work is adjusted accordingly (e.g. 
L36
 
= [M]L2). The omitted residues consist of the ER-localization signal peptide and an unstructured 
linker region detrimental for crystallization. The original cDNA was purchased from DNA 2.0 as codon-
optimized for E. coli. HSP47 variants with three different affinity-tags were used: one with a C-terminal 
Strep[II]-tag (HSP47 C-Strep), one with a C-Terminal His6-tag (HSP47 C-His6), and one with a N-
Terminal GST fusion (HSP47 N-GST). The first two constructs were provided by Dr. Jan Gebauer at 
the beginning of this work, while the latter was cloned by the author. For investigation of the pH-
dependent client release mechanism, key histidine residues in HSP47 were substituted with asparagine 
or alanine as described under 2.2.4. The success of mutagenesis was validated via Sanger sequencing 
performed by GATC Biotech. 
Collagen Model Peptides 
Initial experiments with CMPs obtained via solid-phase peptide synthesis were abandoned in favour of 
heterologously expressed CMPs carrying a C-terminal bacteriophage T4-Fibritin Foldon-domain, a 
trimeric beta-hairpin propeller which bestows the triple-helical CMP species a higher thermostability142. 
The constructs utilized in this work consist of the collagenous host-guest system (GPP)5-(GlyProYaa)-
(GPP)6 (Yaa=Asp, Arg), flanked C-terminally by the Foldon-domain and N-terminally by either a twin 
Strep[II]-tag or by a His6-tag. Unless otherwise stated, all mentions of CMP in this work refer to this 
construct, with the amino acid in position Yaa also specified when necessary (e.g. CMP-D18). The 
plasmids encoding for the Foldon constructs were a generous donation by Dr. Manuel Koch. 
For crystallization experiments, synthetic CMPs purchased from Biomatik were utilized. The 
designation used in this work denotes the total length of the peptide together with the position of the 
residues required for HSP47 binding (e.g. (18)T8R10 denotes the peptide (GPP)2-GPTGPR-(GPP)2). 
Incorporation of hydroxyprolines in the Xaa position is indicated by the prefix Hyp (i.e. Hyp(21)R15).  
3.1.2 Heterologous Protein Expression in E. coli 
Optimal expression conditions for HSP47 (C-Strep), HSP47 (C-His6) and both CMP constructs had 
been previously established and were only changed slightly over the course of this work. In case of 
HSP47 (N-GST), these were determined via small-scale test expressions. Of all the constructs and 
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mutants that were attempted to be produced, only the two mutants HSP47H315N and HSP47H386N failed 
to express. The expression parameters yielding the largest amount of soluble protein are summarized 
for each construct under table 3.1. 
Table 3.1 │ Optimal expression conditions for various protein constructs. 
Construct Base Vector Induction parameters Expression time 
  T / °C OD600 [IPTG] / mM t  / h 
HSP47 (C-Strep) pJexpress411 37 0.6 0.5 4 
HSP47 (C-His6) pET-22(b) (+) 37 0.6 0.5 4 
HSP47 (N-GST) pGEX-4T1 30 0.6 0.1 5 
CMP (N-Strep) pET-30a (+) 20 1.0 1 16 
CMP (N-His6) pET-28a (+) 20 1.0 1 16 
 
3.1.3 Protein Purification 
The expressed proteins were enriched from crude cell lysate using affinity chromatography and 
subsequently subjected to SEC. Typical SEC elution profiles of the various constructs are displayed in 
Figure 3.1. SDS-PAGE analysis confirms that the two-step purification protocol yields protein of 
satisfactory purity (Fig. 3.2).  
 
 HSP47 
(N-GST) 
HSP47 
(C-Strep) 
HSP47 
(C-His6) 
CMP 
(N-Strep) 
CMP 
(N-His6) 
MW / kDa 69.8 44.6 44.1 31.5 26.7 
 
Figure 3.1│Size-exclusion chromatograms of protein constructs. Displayed are typical SEC elution profiles 
of wild-type HSP47 (top left) and CMP (top right) constructs. All runs were performed on a HiLoad Superdex 
S200 16/60 column using a flow rate of 1 ml/min. Due to differences in yield, A280nm was normalized to the highest 
signal for better visualisation before plotting against the column volume. (Bottom) The corresponding molecular 
weight of the constructs. 
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3.1.4 Protein Quality Control 
Differential Scanning Fluorimetry 
The thermal stability of the generated mutants was assessed via DSF. Excluding H238N, all mutants 
were observed to possess Tm values very close to that of the wild-type (Tm = 57 °C), indicating that the 
mutants were stably folded (Fig. 3.3). H238N, on the other hand, displayed a Tm 12 °C below wild-
type, implying a substantial impairment of the structural integrity by the mutation. This is also reflected 
in the aggregation-prone character of the mutant. DSF was further used to monitor the stability of 
HSP47WT in the pH range relevant to this work (Fig. 3.4). The Tm can already be seen to decrease 
discernibly below pH values of 6.5 and at pH 5.6 plummets to 10 °C below its value at neutral pH. 
One peculiarity observed for HSP47 in these experiments was the exceptionally high SYPRO Orange 
fluorescence intensity measured prior to the thermal unfolding of the protein. In a typical thermofluor 
experiment, the initial fluorescence intensity is indistinguishable from the background, while in the case 
of HSP47 it even surpasses the maximum signal generated by full unfolding of the protein. This suggests 
that the dye is shielded from the solvent by native HSP47, presumably due to the presence hydrophobic 
binding sites. The gradual decrease of this high initial fluorescence may be attributed to the shift of the  
 
Figure 3.2│Quantitative SDS-PAGE of 
purified proteins. Coomassie/TCE-stained 
SDS-Polyacrylamide gels of purified 
proteins. (Top) HSP47 histidine mutants 
were generated based on the C-Strep 
construct and used for interaction studies. 
(Bottom) HSP47 and CMP constructs used 
in HTRF and other experiments. Each lane 
was loaded with 2 µg protein. M = Marker. 
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Figure 3.3│Thermal stability of HSP47 mutants. For the determination of Tm values, DSF was performed using 
0.1 mg/ml HSP47 in McIlvaine buffer pH 7.5. All mutants bar H238N show a thermal stability similar to the wild-
type; H238N, however, is significantly destabilized and displays a decrease of 12 °C in Tm (45 °C) compared to 
the average (57 °C). 
 
 
pH 7.5 7.0 6.5 6.2 6.0 5.8 5.6 
Tm / °C 56.5 57.0 56 55.5 54.5 53.0 46.5 
 
Figure 3.4│pH-dependency of HSP47WT thermal stability. SYPRO Orange fluorescence emission intensity is 
plotted against temperature for 0.1mg/ml HSP47WT in McIlvaine buffer with the indicated pH (top left). The Tm 
corresponds to the inflection point of the first derivative of the thermograms (top right) and is listed for the 
indicated pH (bottom). Blank specifies conditions without protein.  
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equilibrium constant between bound and unbound dye towards the latter, resulting in increased 
quenching.  
Close inspection of the thermograms at pH 5.6 and 5.8 reveals two peculiarities which could be 
interpreted such that the protein is already partially or fully denaturing: 
(i) The initial fluorescence intensities are typically higher below pH 6.0, suggesting an 
increase in the total area of exposed hydrophobic surfaces via partial or full unfolding, 
and  
(ii) The increase in fluorescence intensity measured during the denaturation process is less 
pronounced, implying that the amount of native protein capable of denaturing is lower. 
Dynamic Light Scattering 
Samples meant for crystallisation experiments were subjected to DLS analysis directly following SEC. 
A polydispersity higher than 10% has been shown to be detrimental for crystal growth143; values below 
this were unfortunately seldom measured for HSP47 samples. In a typical batch of purified protein, 
polydispersities ranged from ~15% for factions corresponding to the peak middle to ~35% for 
peripheral factions. An arbitrary limit of 25% polydispersity was chosen and factions with a higher 
polydispersity discarded for subsequent crystallization experiments. 
3.2 HSP47 Lacks the Serpin-Typical Hyperthermostable Conformation 
The expression vector for a HSP47 (C-strep) construct containing the RCL of α1-antitrypsin 
(HSP47α1AT-RCL) (Fig. 3.5) was provided by Dr. Jan Gebauer. The protein was successfully expressed 
and purified using the standard protocol for HSP47 (C-Strep). Fig. 3.6 compares the elution profiles of 
HSP47α1AT-RCL and wild-type HSP47 in preparative SEC; the larger loop of the mutant leads to a slightly 
earlier elution. The ratio of the main peak to the characteristic shoulder, or in other words of monomeric 
HSP47 to the trimeric species, is marginally decreased in case of the mutant. This need not be a 
meaningful observation, though, since the formation of the latter is sensitive to relatively small 
differences in the age and concentration of DTT as experienced by the author and reported elsewhere121.  
 
HSP47WT: G329-NPFDQDIYGREELRSP-K346 
HSP47α1AT-RCL: G329-TEAAGAIQEEAIPM  SIPPKL-K350 
Figure 3.5│RCL sequences of wild-type HSP47 and the α1AT-RCL substituted mutant. The dashed line 
carboxyterminal to the “bait” methionine in the α1AT-RCL represents the scissile bond targeted by Elastase. The 
native RCL does not contain any cleavage sites for elastase. 
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The thermostability of the RCL mutant at neutral pH was assessed using DSF. HSP47α1AT-RCL was found 
to have a slightly lower Tm (51.5 °C) compared to the wild-type (54 °C) (Fig 3.7); this, together with 
the SEC results, suggests that the protein is stably folded. It should be noted that the Tm of wild-type 
HSP47 as determined here is lower than the Tm reported above (57 °C, see 3.1.4); this stems from the 
use of different buffer systems (HBS in this case, as opposed to McIlvaine buffer). 
 
Figure 3.7│ Tm values of wild-type HSP47 and the α1AT-RCL substituted mutant. DSF was used to compare 
the thermal stability of the mutant with that of the wild-type. (Left) SYPRO Orange fluorescence intensity is 
plotted in triplicate against temperature for 0.1mg/ml HSP47 in HBS. (Right) Tm corresponds to the inflection 
point of the first derivative of the thermograms. Blank specifies conditions without protein.  
 
Both wild-type HSP47 and the RCL mutant were then subjected to limited proteolysis with porcine 
pancreatic elastase type I (PPE, Sigma-Aldrich). The protein concentration was adjusted to 0.2 mg/ml 
in 25 mM NH4HCO3 (pH 8.2) buffer and PPE was added in a 1:1 stoichiometry. The mixture was 
incubated at 37 °C and the reaction monitored via SDS-PAGE. Samples retrieved for SDS-PAGE were 
immediately mixed with Laemmli-buffer and heated for 5 min at 95 °C in order to denature proteins 
and stop the reaction. As can be seen in Fig. 3.8, PPE digest of HSP47WT and HSP47α1AT-RCL shows 
differences in progression and products. In the case of wild-type HSP47, a band some 3 kDa smaller  
  45 – 
  35 – 
kDa 
Figure 3.6│Size-exclusion 
chromatography and quanti-
tative SDS-PAGE of 
HSP47WT and HSP47α1AT-RCL. 
Comparison of size exclusion 
profiles of HSP47WT and 
HSP47α1AT shows that the 
mutant elutes marginally 
earlier than wild-type HSP47 in 
SEC (left). Coomassie stained 
SDS polyacrylamide gel of 2µg 
protein. The mutant can be seen 
to run at a higher molecular 
weight (right).  
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Figure 3.8│PPE digest of wild-type HSP47 and the α1AT-RCL substituted mutant. Samples were retrieved 
at the indicated time points and the progress of proteolysis analysed via SDS-PAGE and Coomassie staining. 
(Left) Digestion of HSP47WT; (Right) Digestion of HSP47α1AT-RCL. M = Marker. The red arrow highlights a 
transiently appearing band which might possibly be the cleaved-off C-terminal part of the protein.  
 
appears after around 15 min. A possible cleavage site which would yield this species can be localized 
in a flexible, solvent exposed loop just C-terminal to α-helix A (V64E65). However, HSP47 is not fully 
converted to this species and both are almost fully degraded after 6h of incubation.    
In the case of HSP47α1AT-RCL, almost all of the protein is converted into two species with a molecular 
weight of ~38 - 40 kDa within 5 min. Concurrently, the appearance of a distinct protein band of small 
molecular weight (red arrow) can be observed. After one hour of incubation, the double band disappears 
and solely the lower weight species can be detected, which then is degraded completely after 3h. It can 
be postulated that the higher weight species of the double band corresponds to HSP47α1AT-RCL after 
cleavage in the RCL and removal of the resulting C-terminal fragment (expected molecular weight: 
37.9 kDa) and that the lower weight species occurs due to further cleavage elsewhere in the protein. 
The low molecular weight band indicated with the red arrow can be assigned to the above-mentioned 
C-terminal fragment generated by cleavage in the RCL (expected molecular weight: 6.7 kDa). 
In order to further investigate the biochemical characteristics of HSP47α1AT-RCL, the PPE digestion was 
up-scaled and repeated. Proteolysis was terminated after 1 h at 37 °C via addition of 0.2 mM PMSF, 
and the mixture was subjected to analytical size-exclusion chromatography (Fig 3.9). The 
chromatogram shows that digested HSP47α1AT-RCL runs at the same volume as the undigested protein, 
indicating that in the C-terminal fragment generated via cleavage in the RCL is still incorporated into 
the native fold, presumably because it harbors β-strands s4B, s5B and s1C, which are still embedded 
into the tertiary structure. 
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The influence of the exogenous RCL on the collagen binding properties of HSP47 was investigated 
using BLI (For details on BLI-Assay establishment please refer to the next section). In comparison to 
the wild-type, HSP47α1AT-RCL was seen to generate a lower maximal response upon association to 
immobilized CMP-R18
 
at neutral pH (Fig. 3.10). Extraction of the koff values revealed a two-fold 
increased dissociation rate for the mutant: the differences in kon, on the other hand, were marginal. In 
crystal structures of HSP47 in complex with CMP, the RCL is seen to be disordered, suggesting that it 
is not involved in interactions with the client. However, it is possible that the increased space 
requirement of the larger α1AT RCL is deleterious for client binding. 
 
Figure 3.10│CMP affinity of the α1AT-RCL mutant. (Left) Comparison of the concentration dependent 
interaction of HSP47WT (black) and HSP47α1AT-RCL (red) with immobilized CMP-R18 in McIlvaine buffer pH 7.5.   
(Right) The kon and koff values were extracted from the sensorgram corresponding to 2 µM protein (dashed line).  
 
 
 
 kon 
/ mM-1∙s-1 
koff 
/ s-1 
KD 
/ µM 
WT 43.03 
± 0.68 
0.029 
± 0.001 
0.67 
± 0.07 
α1AT-RCL 38.46 
± 0.86 
0.058 
± 0.001 
1.51 
± 0.09 
Figure 3.9│Size-exclusion 
chromatography of Elastase 
digested α1AT-RCL mutant. 
The retention volume of the 
HSP47α1AT-RCL mutant in SEC 
is not affected by cleavage in 
the RCL (left). In SDS-PAGE 
analysis, the cleaved off 
fragment (red arrow) runs 
separately (right). 
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3.3 Characterization of the HSP47 - Collagen Interaction 
3.3.1 Establishing Biolayer Interferometry Experiments 
Initial considerations focused on assigning the role of ligand and analyte to the interaction partners (i.e.  
whether HSP47 or the CMP should be immobilized onto the sensor) as well as selecting the method of 
immobilization. Owing to the fact that the obtained signal is directly proportional to the relative change 
of the density and thickness of the biolayer, it was obvious that loading the smaller CMP onto the sensor 
and detecting the binding of the larger HSP47 would provide a better signal to noise ratio. As for the 
method of immobilization, loading His6-tagged ligand onto Ni-NTA-functionalized sensors or loading 
biotinylated ligand onto streptavidin-functionalized sensors was considered. While the former foregoes 
potentially problematic chemical modifications of the ligand with biotinylating reagents, there were 
concerns that performing experiments in the pH-range of the pKa of histidine sidechains would lead to 
increased dissociation of ligand from the sensor especially in more acidic conditions, which would 
require careful control experiments to account for. Biotinylation of CMPs was found to be straight 
forward, and thus the latter immobilization strategy was chosen. 
One problem which arose in using streptavidin sensors was that HSP47 is capable of unspecific binding 
to the streptavidin coated biosensors. However, this unspecific binding can be supressed via the 
inclusion of 0.01% (v/v) Tween-20 and/or 0.1% (w/v) BSA in the buffer. Alternatively, unspecific 
binding sites on the biosensor can be saturated via repeated exposure of the sensor to HSP47 in a 
blocking step prior to the experiment (Fig 3.11). The latter strategy was chosen for all subsequent 
biolayer-interferometry experiments. 
 
Figure 3.11│HSP47 shows unspecific binding to SA biosensors. (Left) HSP47 (1.5 µM) associates to a blank 
SA biosensor in standard assay buffer (black). This unspecific binding can be largely suppressed with buffer 
additives such as 0.1% (w/v) BSA (red) or 0.01% Tween-20 (green) and practically eliminated by simultaneously 
employing both (blue). (Right) Repeated association/dissociation cycles of HSP47 (1.5 µM) to a CMP-R18-biotin 
loaded SA biosensor saturate the unspecific binding sites and give reproducible curves after 3 cycles (orange and 
red). The unspecific binding is noticeable in the first cycle (violet) through the extended time required for the 
association curve to reach a plateau and the higher residual response after the dissociation, indicating some protein 
has irreversibly bound to the biosensor. 
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3.3.2 Characterization of the HSP47 - Collagen Interaction Using BLI 
Kinetic parameters and KD of the HSP47 - collagen interaction 
The established assay was used to quantify the kinetic parameters as well as the KD of the HSP47 - 
CMP-R18 interaction. The binding of a serial dilution of HSP47 (Analyte, A) to immobilized CMP-
R18 (Ligand, L) is displayed in Figure 3.12. The observed reaction A + L ↔ AL* follows pseudo first-
order kinetics, since under standard assay conditions the analyte concentration [A] is in great excess 
while the total ligand concentration [L] stays constant throughout. The “true” association rate (kon) as 
well as the dissociation rate (koff) can thus be determined via graphing the apparent association rate 
(kobs) against analyte concentration [A] according to the equation of a first-order reaction 
 
The apparent association rates corresponding to different HSP47 concentrations were acquired via 
fitting a monophasic exponential association function to the association phase of the sensorgrams. The 
values were then plotted against the HSP47 concentration to yield kon and koff as the slope and y-intercept 
of the applied linear fit, respectively. The apparent association rate for 20 µM HSP47 was not included 
in the fit, since the data loses linearity at high concentrations, presumably due to saturation of the 
biosensor. 
   
kon / mM-1 ∙ s-1 koff / s-1 KD / µM 
21.6 0.013 0.60 
 
Figure 3.12│ BLI response in dependency on analyte concentration. Binding of a serial dilution of HSP47WT 
(C-Strep) to a biosensor loaded with biotinylated CMP-R18
 
(left). The kobs values were extracted via fitting a 
monophasic exponential association function (dashed lines) to the association curves and graphed against HSP47 
concentration (right). The increase in kobs with concentration loses linearity at higher concentrations; thus the data 
for 20 µM HSP47 (hollow point) was omitted for the linear fit (red line). According to Eq. 5, the association rate 
and dissociation rate are given by the slope and y-intercept of the line, respectively. The dissociation constant can 
be calculated via KD =  koff / kon (bottom). 
 
 
* It is assumed that HSP47 binds CMP in a 1:1 stoichiometry (please refer to 3.3.3) 
 
(Eq. 5) kobs = kon [A] + koff 
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It is notable that the association curves never quite reach an equilibrium; this was still the case in 
experiments in which the association time was extended up to the recommended maximum of 4 minutes 
(not shown). This limitation is imposed by evaporation of solvent in the small analyte reservoir (4 µl), 
which increases sample concentration and also changes the optical density of the liquid medium and 
thus increasingly interferes with the measurement. As discussed under 4.2.1, in case of the HSP47 - 
collagen complex the expected time to reach equilibrium is well below the limit imposed by the BLI 
method, indicating that either the unimolecular binding model is erroneous, or that the observed “drift” 
is due to unspecific binding. 
HSP47 client-affinity decreases with pH 
The binding of 2.5 µM HSP47WT (C-Strep) to biotinylated CMP-R18 immobilized on a SA-biosensor 
was monitored in a pH range of 6.0 to 7.5. The kinetic parameters of the individual binding isotherms, 
kon and koff, were extracted as described under 2.4.11 and allowed the calculation of the KD, which was 
subsequently plotted against the pH (Fig. 3.13) Analysis of the experimentally derived parameters leads 
to the conclusion that the increase in KD can be largely attributed to an increase in koff. 
 
pH Rmax,t=60s kon / mM-1∙s-1 koff / s-1 KD / µM 
7.5 2.62 39.6 ± 1.1 0.028 ± 0.001 0.71 ± 0.03 
7.0 2.26 36.6 ± 1.7 0.042 ± 0.004 1.16 ± 0.15 
6.5 1.66 38.5 ± 5.9 0.074 ± 0.004 1.99 ± 0.39 
6.0 0.83 22.4 ± 6.8 0.197 ± 0.004 4.49 ± 0.55 
 
Figure 3.13│pH-dependency of the HSP47 - Collagen interaction visualized with BLI. (Left) A decrease in 
pH leads to less binding of HSP47 to immobilized CMP-R18-biotin, as indicated by the decrease in maximal 
response. The kon and koff values were extracted from a monophasic exponential function fitted to the data of the 
association (green) and dissociation (red) phases, respectively. (Right) The calculated KD values are shown 
plotted against pH; at pH 6, the KD has increased more than 6-fold compared to pH 7.5. (Bottom) Summary of 
experimentally determined parameters for indicated pH values. All sensorgrams were recorded in triplicate. 
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Looking at the individual kinetic parameters, it is immediately evident that the determination of koff is 
much more precise than the determination of kon. The higher error observed for the latter is primarily 
induced by discrepancies between the mathematical fit and the recorded association curve, as can be 
seen in the left panel of Fig. 3.13. The error is furthermore seen to be more substantial at low pH, where 
the total signal to background ratio is low and presumably increased denaturation or aggregation of 
HSP47 occurs. 
3.3.3 Stoichiometry of the HSP47 - Collagen Interaction 
Triple-helical, homotrimeric collagen can accommodate more than one HSP47 molecule per stagger 
unit containing the GPR motif - in fact, 2 HSP47 molecules per trimeric CMP is the only stoichiometry 
ever observed in crystal structures up to date. In order to investigate whether this is also the case in 
aqueous solution and to verify that the mono-phasic association model used for the evaluation of BLI 
data is valid, ITC experiments were performed as described under 2.4.9. In experiments conducted in 
HBS pH 7.5 at 20 °C, the binding was revealed to be endothermic (ΔH = 11.67 kJ·mol-1), indicating 
that the driving force of the interaction is of entropic origin (ΔS = 159.79 J∙K-1·mol-1) (Fig.3.14). The 
comparison of crystal structures of HSP47 alone and in complex with CMPs reveals that HSP47 does 
not undergo any significant conformational changes upon client-binding, ruling out any contribution of 
protein rearrangement to the increase in entropy. It can be assumed that the largest contributing factor 
is the release of water molecules from clathrates at the relatively hydrophobic interaction interfaces. 
  
Figure 3.14│Thermodynamic parameters of the 
HSP47 - Collagen interaction. (Top)  300µM HSP47 
in PBS (pH 7.5) was injected in 2.5µl steps to the 
reservoir containing 350µl 30µM CMP-R18 in PBS 
(pH 7.5) at 20°C. The difference in heating power 
between sample and reference cells was recorded; the 
positive sign indicates that the association is 
endothermic. (Bottom) The stoichiometry and 
thermodynamic parameters of the interaction can be 
extracted via the Wiseman plot, in which the heat 
taken up per injection is plotted against the ratio 
between total HSP47 concentration and total CMP 
concentration.  
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The calculated KD value of 0.57 µM is in accordance with the ones obtained via BLI (0.60 µM, 0.71 
µM), while the calculated stoichiometry of 0.79 (HSP47 : CMP) can be assumed to deviate from 1 due 
to inaccurate determination of protein concentration or the presence of binding-incompetent HSP47.  
3.4 Molecular details of the pH-dependent client release 
3.4.1 Systematic Analysis of Histidine Residues in HSP47 
As mentioned under the aims of this thesis, histidine residues are the prime candidates for triggering 
the pH-induced client release of HSP47. In order to pinpoint the histidine residues involved in this 
process, the 14 histidines present in HSP47 were subjected to structural and phylogenetic analysis and 
their protonation behaviour assessed with molecular dynamics simulations, which subsequently guided 
the selection of mutants to be generated and analysed in-vitro.  
Phylogenetic analysis 
The phylogenetic sequence alignment was prepared by Dr. Jan Gebauer and visualized by the author 
(Fig. 3.15). Within the class of mammalia, all histidines are conserved; variations are primarily observed 
in more distant ancestors such as fish, amphibians, reptiles and birds. His108 and His353 are found in 
other serpins clades as well (PEDF, Antitrypsin, Antithrombin), suggesting that they are a common 
feature of the serpin fold. His108 is located near the N-terminal end of hE and serves as a H-bond 
acceptor for Tyr154 on hD, a residue also conserved in other serpins. His353, which is part of β-sheet 
A and located at the shutter region, is buried in the hydrophobic core of the protein. In orthologs of 
HSP47, His238, His315 and His386 are seen to be strictly conserved. The imidazole side chain of 
His315, located at the C-terminus of s6A, is buried in the same hydrophobic region as the side chain of 
His353, which in the tertiary structure is immediately adjacent to it. His238 and His386 are constituents 
of β-sheet C, the scaffold of the interaction interface. The conservation and immediate vicinity to bound 
collagen suggests a crucial role for these residues in client binding and release. His153, His158, His209, 
His215, His274 and His320 are largely conserved, with few exceptions found in Actinopterygii, while 
in the case of His216, His262 and His273, there are substantial variations. 
The localization of histidine residues in the three dimensional structure of HSP47 is displayed in Fig. 
3.16. 
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Figure 3.15│Phylogenetic analysis of histidine residues in HSP47. Histidines are highlighted with black and 
color coded according to their degree of conservation: strictly conserved in HSP47 as well as in the listed Serpins 
(blue), strictly conserved only in HSP47 (green), conserved with few exceptions (yellow), least degree of 
conservation (red). The amino acids replacing histidines are highlighted with red.  
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Figure 3.16│Conservation and basicity of histidine residues in HSP47. Crystal structure of HSP47 with CMP 
(18)T8R11 (white: leading strand, grey: middle strand, black: trailing strand). (Left) The 14 histidine residues of 
HSP47 are color-coded according to their degree of conservation. Blue: Strictly conserved in HSP47 and Serpins, 
green: Strictly conserved only in HSP47, yellow: Conserved in HSP47 with few exceptions, red: Least degree of 
conservation. (Right) The same residues are color-coded according to the calculated percentile change in the 
doubly protonated faction during the transition from pH 7.0 to 6.0. Blue: ˂ 0% green: ≈ 0%, yellow: ˂ 25%, red: 
> 25% (PDB ID: 3ZHA) 
 
Molecular dynamics simulations 
The in-silico experiments were performed by Eileen Socher under supervision of Prof. Dr. Heinrich 
Sticht at the University of Erlangen. The crystal structure of HSP47 in complex with a 18 residues long 
CMP harbouring an arginine per α-chain at position Yaa (PDB entry code: 3ZHA) served as the 
template for constant pH molecular dynamics (CpHMD) simulations run at a temperature of 37 °C for 
pH 4.0, 5.0, 6.0, 7.0 and 8.0. For each of the 14 histidines, the fraction of doubly protonated residues 
was determined at the indicated pH and enabled the calculation of the pKa values (table 3.2). It is notable 
that His215, His238 and His274 remain singly protonated over the whole tested pH range. While the 
influence of the microenvironment on amino acid basicity is hard to predict, this decrease can possibly 
be attributed to the proximal presence of positively charged residues (Lys213 + Lys217, Arg222 and 
Lys252, respectively). His386, on the other hand, is already doubly protonated at pH values as high as 
8, possibly due to the proximity to the carboxylate moiety of the neighboring Asp385 as well as the H-
bond formed with the backbone carbonyl of Pro272. The histidines located at positions 153, 158, 262, 
273, and 315 show a significant increase in the doubly protonated fraction (˃25%) going from pH 7.0 
to 6.0; these were judged to be potential triggers for client release and were investigated further along 
with all other interface histidines (His215, His216, His238, His274 and His386). Intriguingly, His353 
was calculated to show a decrease in the doubly protonated faction under more acidic conditions. This  
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Table 3.2│Basicity of histidine side chains in HSP47 as predicted by CpHMD. Asterisks indicate that the 
histidine is located at the collagen binding interface. The residues in bold were selected for further in-vitro studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
behaviour is hard to explain without pronounced alterations of the microenvironment, which in itself 
seems rather unlikely, considering the histidine in question is buried in the core of the protein 
 
3.4.2 Role of HSP47 Histidines in pH-Dependent Client Release 
Histidine Scanning Mutagenesis 
HSP47 (C-Strep) constructs with a single His → Asn mutation at positions 153, 158, 215, 216, 262, 
273, 274, 315 and 386 as well as tandem His → Asn mutations at positions 215 + 216 and 273 + 274 
were generated as described under 2.2.4. The rationale for choosing asparagine as a substitute was that 
its side chain, among all natural amino acids, displays the largest structural and stereoelectronic 
similarity to the imidazole moiety of histidines and does not undergo protonation at the relevant pH. 
Following initial experiments, where the H273N + H274N double mutant was identified to have 
attenuated response to decreasing pH (vide infra), His → Ala mutations were introduced at these 
positions with the aim of excluding asparagine-specific effects. In order to simulate the protonated form 
of the histidines and investigate the overall impact of charge, lysine and aspartic acid were also 
 
Residue No. 
% change in doubly 
protonated fraction 
(pH 7.0 → pH 6.0) 
 
Theoretical 
pKa 
108 + 9.1 5.59 
153 + 60.9 6.21 
158 + 31.1 5.50 
209 + 0.7 5.08 
215* - 0.1 ˂ 4 
216* + 15.3 5.40 
238* + 0.3 ˂ 4 
262 + 63.7 6.51 
273* + 29.4 5.23 
274* + 0.4 ˂ 4 
315 + 58.2 5.63 
320 - 1.7 4.47 
353 - 19.4 5.18 
386* - 0.1 ˃ 8 
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incorporated at said positions. Finally, His273 was substituted by the amino acids encountered in 
Actinoptergyii and Hyperoartia (Leu, Phe and Tyr) in order to further understand the influence of the 
amino acid at this position on client-release. The generated mutants were tested for their affinity to 
CMP-R18 at pH 6.0, 6.5, 7.0 and 7.5 using biolayer interferometry as described under 2.4.11. The 
sensorgrams and extracted parameters koff, kon and KD are shown in the appendix (Fig. A.1, tables A.1-
3). For reasons that will be discussed under section 4.2.1, determination of kon and thus also the 
calculation of KD was accompanied with substantial error, and the interpretation of the data will be 
primarily through the dissociation rate koff. 
Non-interface histidines are not involved in client-release 
According to MD simulations, the non-interface residues His153, His158, His262 and His315 are 
subject to the largest increase in the fraction of doubly protonated side chains during the transition from 
pH 7 to 6. This suggests that these residues are potential triggers, ostensibly relaying information about 
their protonation states to the collagen binding interface via conformational rearrangements. However, 
BLI analysis of H153N and H158N shows that the collagen binding behaviour of the mutants is not 
altered compared to wild-type, while the in case of H262N the interaction with the CMP is destabilized 
at increasingly acidic conditions (Fig. 3.17). The mutant H315N failed to express, which is unsurprising 
considering that the histidine is located in the protein core and strictly conserved in the HSP47 family.  
 
 
Figure 3.17│ Role of non-interface histidines 
in the pH-sensitivity of client release. koff (top 
left), kon (top right) and KD (bottom) values for 
the non-interface histidine mutants are compared 
to those of the wild-type in the pH range 6.0 - 
7.5. The parameters were extracted from 
association and dissociation curves recorded via 
BLI at the respective pH. H262N displays a 
slightly increased pH-sensitivity of binding 
while H153N and H158N are not distinguishable 
from the wild type.  
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His215 is important for collagen binding 
Histidines 215 and 216 are located at the fringe of the binding interface, with the side-chain of His215 
being situated in close proximity (roughly 3.9 Å) to the Yaa-3 residue in the CMP strand with a -1 
stagger compared to the one harbouring the arginine recognized by HSP47. The calculated pKa of 
His215 is abnormally low (˂4), making it unlikely that this residue is one of the pH triggers, since the 
increase in the doubly protonated faction as the pH approaches 6 can be expected to be negligible. As 
stated before, this rather drastic decrease in the pKa might be attributed to the proximity of two lysine 
residues (Lys213 and Lys217), although why this effect is attenuated in case of the neighbouring His216 
is unclear.  
Of all the tested His → Asn mutants, H215N and the double mutant H215N + H216N were the only 
ones to display significantly increased koff (Fig. 3.18) and KD values as well as a decreased Rmax at all 
tested pH values. Since H216N is seen to behave similar to the wild-type, the effect observed in the 
double mutant can be attributed solely to His215, implying that this residue is important for the HSP47 
- collagen interaction.  
  
 
 
Figure 3.18│ Role of interface histidines 215 
and 216 in the pH-sensitivity of client release. 
Depicted are the changes in koff (top left), kon (top 
right) and KD (bottom) values over the pH range 
6.0 - 7.5 for the indicated histidine mutants in 
comparison to the wild type. The parameters were 
extracted from association and dissociation 
curves recorded via BLI at the respective pH. The 
mutation H215N induces a higher koff throughout 
the whole tested pH range; this is also observed in 
the double-mutant H215N + H216N. Regarding 
the dissociation rate, the mutation H216N is 
silent. 
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The mutation H238N abolishes collagen binding 
His238, located on s1C close to the centre of the binding interface, is one of the three histidines that are 
strictly conserved in the HSP47 family but not in other Serpins. Although the H238N mutant expressed 
well, the protein was observed to be rather unstable and prone to precipitation over time, particularly at 
mildly acidic pH. Strikingly, this single mutation lowers the Tm of the protein by up to 12 °C (please 
refer to section 3.1.3). In order to verify the structural integrity of the mutant, far-UV CD spectra were 
recorded, which indicated that at neutral pH, the mutant is stably folded and similar in secondary 
structure composition to the wild-type (Fig. 3.19, left). The binding of HSP47H238N to CMP-R18, 
however, was not detectable via BLI, even at a pH of 7.5 (Fig. 3.19, right). 
  
Figure 3.19│The H238N mutation abolishes CMP binding. (Left) Comparison of CD spectra recorded at pH 
7.5 for wild-type HSP47 as well as the H238N mutant confirms that the latter is stably folded. (Right) Serial 
dilutions of wild-type (black curves) as well as HSP47H238N (red curves) were tested towards their affinity to 
immobilized CMP-R18 using BLI. Binding of HSP47H238N was not detected.  
 
 
This finding was further investigated via MD simulations. Figure 3.20 displays a comparison of the 
wild-type crystal structure with a snapshot of HSP47H238N modelled without the collagen client. It can 
be seen that the side chain of Arg222, a critical residue for collagen binding, is in the wild-type 
prepositioned by a network of H-bonds involving Asp220, His238, Ser305 and Tyr383. His238 is 
wedged in between Asp220 and Ser305, serving as a H-donor to the former via its tele-nitrogen atom 
and as a H-acceptor to the latter via the pros-nitrogen atom. In the H238N mutant, however, Asp220 
cannot maintain the salt bridge to Arg222, which instead displaces the phenol side chain of Tyr383 to 
interact with Asp385. This short circuits the two residues crucial for client binding, resulting a total loss 
of affinity towards collagen. 
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In additional MD simulations, distances between key amino acid side-chains were monitored over time 
as an indicator for the stability of the interaction (Fig. 3.21). In the wild-type, the distance between 
Arg222-Cζ and Asp220-Cγ is locked at around 4 Å independent of collagen binding, indicating a 
preorganization of the arginine side-chain. In case of the H238N mutant, however, the determined 
interatomic distance starts to fluctuate, and a conformer where the indicated atoms are roughly twice as 
far apart becomes predominant, suggesting a dynamic equilibrium between the binding-competent and 
short-circuited forms. The same pattern is reflected in the distance between Arg222-Cζ and Asp385-
Cγ: the stable separation by approximately 7 Å yields to a dynamic equilibrium in HSP47H238N, with the 
predominant conformer placing the indicated atoms roughly 4.5 Å of each other. Over a large period of 
the simulated timespan, the distance between the hydroxyl-O of Ser305 and the tele-N of His238 is too 
large for H-bonding, and client binding noticeably stabilizes the transiently forming H-bonds. A specific 
effect of the H238N mutation is the rather static distance of 2 Å between the hydroxyl-O of Ser305 and 
the carboxamide-N of Asn238, indicating a stable interaction between these residues.  
 
 
Figure 3.20│The H-bond network centered 
on R222 is reorganized in the H238N 
mutant. (Left) Crystal structure of wild-type 
HSP47 in complex with CMP (18)T8R11 
(PDB ID: 3ZHA). (Right) Snapshot of 
uncomplexed HSP47H238N obtained via 
CpHMD simulations. In the wild type, H238 
interacts with D220 (red dashed lines) which 
in turn forms a salt-bridge with R222 (yellow 
dashed lines). Additionally stabilized by a H-
bond with Y383 (grey dashed line), R222 is 
thus oriented such that it can interact with a 
backbone carbonyl of the collagen chain. This 
interaction is essential for collagen 
recognition, along with the salt-bridge 
between D385 and R8 (grey dashed line). The 
mutation H238N leads to a rearrangement of 
the residues, resulting in an intramolecular 
salt-bridge between D385 and R222 (green 
dashed lines), disabling two critical contacts 
for collagen binding at once. (Figure taken 
from Oecal et al.184) 
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The collagen binding of mutant H273N + H274N is less sensitive to a decrease in pH 
His273 and His274 are located at the edge of the binding interface, close to the salt bridge between 
D385 of HSP47 and the arginine of the collagen. While His274 is rather well conserved across the 
HSP47 family, His273 is often found to be substituted with asparagine (Sauropsida) or tyrosine 
(Actinoptergyii) as well as with phenylalanine or leucine in individual cases. According to MD 
simulations, the fraction of doubly protonated His273 residues increases from 3.3% to 32.7% upon 
reduction of the pH from 7 to 6, while His274 is virtually not protonated. This difference in basicity is 
dictated by the microenvironment: the imidazolium cation is stabilized in case of His273 through the 
H-bond formed with Asp247, and destabilized in case of His274 by the close proximity to the positively 
charged Lys252. Interestingly, while singly replacing either of the histidines with asparagine did not 
discernibly influence the HSP47 - CMP interaction, concurrent substitution of both histidines led to a 
markedly attenuated increase of the koff with increasing acidity (Fig. 3.22). This would imply that 
protonation of either one of the histidines is sufficient to induce client release. The experiments were 
repeated using His → Ala mutants; these behaved in the same pattern, albeit with the inconspicuous but  
Figure 3.21│Conformational stability of 
selected side-chain interactions. The distances 
between indicated atoms were monitored over 
simulation time for collagen-bound HSP47WT 
(black squares), free HSP47WT (grey circles) and 
free HSP47H238N (colored triangles). The 
interaction between R222 and D220 is stable and 
not influenced by the presence of collagen in the 
wild type, but disrupted in the mutant (top). The 
formation of the intramolecular salt bridge 
between R222 and D385 in the mutant is reflected 
by the decreased interatomic distances (middle). 
Client binding slightly stabilizes the H-bond 
between H238 and S305; the H-bond between 
N238 and S305 in the mutant, however, is stable 
regardless of the presence of collagen (bottom). 
(Figure taken from Oecal et al.184) 
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nonetheless important detail that H273A responds less to a change in pH than H273N, which in turn is 
slightly less pH-sensitive than the wild-type. 
Figure 3.22│ Role of interface histidines 273 and 274 in the pH-sensitivity of client release. │ Histidines 
273 and 274 were substituted with asparagine (left column) and alanine (right column) and the pH-
dependency of their dissociation rate (top row), association rate (middle row) and dissociation constant 
(bottom row) determined via BLI. While mutation of His274 did not affect binding behaviour, the increase in 
koff with lower pH is attenuated in case of His273 mutants as well as the double mutants. The impact of the 
mutation increases in the order H273N < H273A < H273N + H274N ≈ H273A + H274A. 
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Influence of charged residues at positions 273 and 274 
The observation that a positive charge, introduced via protonation at either position 273 or 274, is 
required to drive client release prompted further studies using amino acids that are uniformly charged 
throughout the tested pH range. For this, both histidines were replaced by either aspartic acid or lysine. 
Concurrent with the idea that a positive charge is required for inducing client-release, H273D and 
H274D were seen to possess slower dissociation rates, especially under the more acidic conditions (Fig. 
3.23). Although the anionic aspartic acid will increase the basicity of the neighboring histidine, the 
positive charge brought in via protonation will be locked in place and neutralized, resulting in 
impairment of client release. Following the same line of thought, incorporation of lysine residues at 
these sites was expected to result in an increased koff and thus a decreased KD at neutral pH values. 
Furthermore, an attenuated or completely abolished pH-dependency of the binding was anticipated. 
However, experimental data revealed that H273K has similar dissociation rates as the wild-type, even 
displaying a slight decrease in the pH-dependency of its binding. This decrease could stem from the 
detrimental influence of the positively charged lysine on the protonation of His274, which in this case 
would seem to be the requirement for client release. The mutant H274K, on the other hand, does display 
a markedly weakened binding compared to the wild-type, with higher koff rates over the whole tested 
pH range. Whether this is the direct result of the positive charge or rather of the increased steric demand 
of the lysine side-chain is unclear. 
 
 
Figure 3.23│Influence of charged residues 
at sites 273 and 274 on the pH-sensitivity of 
client-release. Changes in koff (top left), kon 
(top right) and KD (bottom) values over the 
pH range 6.0 - 7.5 are displayed for the 
charged mutants in comparison to wild type. 
With the exception of H274K, which displays 
a markedly decreased affinity to CMP over the 
whole tested pH range, introduction of 
charged residues leads to a less pronounced 
increase in koff at low pH. 
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The residue in position 273 fine-tunes pH-dependency of client-release in many organisms 
As previously mentioned, mutation of His274 did not have any significant impact on the pH-
dependency of client release. In case of H273A and H273N, however, the response of the dissociation 
rate to more acidic conditions was slightly attenuated and furthermore discernibly different between the 
mutants. While it is certainly unexpected that substitution of the less well conserved histidine causes a 
larger perturbation on client-release, the amino acid in position 273 might be involved in the fine-tuning 
of the basicity of His274 in SERPINH1 orthologs. Coincidentally, initial experiments had already 
covered the NH motif found in Sauropsida; these were supplemented with analysis of the motif YH, 
common to Actinopterygii, as well as the infrequently encountered motifs LH and FH.  (Fig. 3.24). 
While the binding behaviour of the mutant with the YH motif was shown to be indistinguishable from 
that of the HH motif, the pH-sensitivity of FH and LH was shown to be less pronounced, similar to the 
previously tested NH and AH motifs. Combining all the acquired data, dissociation rates at pH 6.0 were 
observed to decrease in the order YH (0.215 s-1) ≈ HH (0.192  s-1) > NH (0.148 s-1) ≈ FH (0.139 s-1) > 
LH (0.112 s-1) ≈ AH (0.111 s-1) > AA (0.080 s-1) ≈ NN (0.071 s-1). If there is any pattern at all, it would 
seem to suggest that that the basicity of H274 decreases the smaller and less polar the neighbouring 
residue is. 
 
Figure 3.24│Substitutions of His273 
encountered in HSP47 orthologs and their 
effect on the pH-sensitivity of client release. 
Changes in koff (top left), kon (top right) and 
KD (bottom) values are graphed over the pH 
range 6.0 - 7.5 for the indicated mutants in 
comparison to wild type. The dissociation 
rates of H273F and H273L are less pH-
dependent than those of the wild-type, while 
H273Y was seen to behave identically. The 
latter is the most common amino acid 
substitution encountered in Actinopterygii.  
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There is no evidence for conformational changes accompanying client-release 
In order to determine whether HSP47 undergoes any pH-induced conformational changes that might be 
responsible for client-release, far-UV CD spectra of the wild-type as well as the pH-insensitive double 
mutant H273N + H274N were recorded at pH 7.5 and pH 6.0. The spectra of both proteins display 
features characteristic for folded proteins with high α-helical content: a broad saddle of negative 
ellipticity above 200 nm, with minima observed at 214 nm and 222 nm (Fig. 3.25). The difference in 
the magnitude of ellipticity between both proteins can be attributed to errors in concentration 
determination, since the overall shape of the curves is identical. The experiment further revealed that 
there are no significant differences in secondary structure between pH 7.5 and 6.0 and suggests that 
conformational arrangements have no effect on the client-binding capacity of HSP47. 
  
 
3.5 High-Throughput Screening for Inhibitors of the HSP47 – Collagen 
Interaction 
3.5.1 Design principles  
Ono et al. have previously utilized HTRF to prove that HSP47 preferentially binds to triple-helical 
collagens117. The basic setup of their assay has been judged to be quite compatible for high-throughput 
screening, and was adopted and optimized for this purpose (Fig. 3.26). One modification introduced 
over the course of this work was the choice of Tb3+-Cryptate as the fluorescence donor over Eu3+-
Cryptate. The latter is, in its excited state, very effectively quenched by CH, NH and OH oscillators, 
necessitating its shielding from bulk water and other buffer components such as TRIS or HEPES144. 
This is usually achieved via inclusion of up to 500 mM KF; the resulting high ionic strength buffer, 
though, is hardly physiological, and the toxicity of fluoride requires special handling and disposal which 
may be complicated to incorporate into the highly standardized and automated high-throughput 
screening process. Fortunately, Tb3+-Cryptate does not show the same quenching properties as its Eu3+ 
counterpart, and allows the circumvention of these problems. 
Figure 3.25│Changes in secondary 
structure of HSP47WT and 
HSP47H273N+H274N between pH 7.5 and 6.0. 
CD spectra of wild type as well as mutant 
HSP47 reveal no changes in secondary 
structure between pH 7.5 and 6.0; in case of 
the latter a slight decrease in the amplitude can 
be observed. This might be attributed to a 
decrease in the concentration of natively 
folded protein at pH 6.0. 
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Figure 3.26 │Schematic depiction of the HT-FRET assay. (A) In case of no interaction between the analytes, 
only the emission of Tb3+-cryptate at 620nm is observed. (B) Interacting analytes bring XL665 into proximity of 
Tb3+-cryptate upon which FRET occurs and emission from XL665 at 665nm is observed. The ratio of the emission 
intensities I665nm/I620nm can be used to quantify the fraction of interacting analytes. (C) Legend. 
 
The choice of the right tag and corresponding binding partner to mediate the interaction between 
analytes and their corresponding FRET donor or acceptor, from now on referred to as reporters, is a 
central aspect of any FRET based binding assay. Ideally, the affinity between the analytes and their 
corresponding reporters would be significantly higher than the affinity between the analytes themselves; 
furthermore, the affinity of each analyte to their corresponding reporter should be of similar magnitude. 
This ensures that both reporters show a comparable level of occupancy, or, in the ideal case, are 
saturated with analyte, increasing the probability of an interaction to be reported. The composition of 
the assay as described by Ono et al. was not modified in this regard: reporter binding was mediated via 
an N-terminal GST fusion to HSP47, which is recognized by αGST-mAb conjugated to the FRET donor 
Lumi4-Tb3+-Cryptate, and biotinylation in the case of the CMP, which in turn is recognized by 
streptavidin conjugated to the FRET acceptor XL665. The corresponding binding affinities (KD values 
in the range of low pM to low nM145 and fM146, respectively) are much higher than that of the HSP47 - 
CMP interaction (KD = 0.74 ± 0.02, as determined with BLI).  
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3.5.2 Characterization of the Assay 
Overview 
The utilized proteins, summarized in table 3.3, were produced as described under section 3.1.  
 
Table 3.3│Proteins used for Assay establishment 
Protein Remarks 
HSP47WT (C-His6) No reporter binding 
HSP47WT (N-GST) Standard analyte 
HSP47D385N (N-GST) No CMP binding 
CMP-R18 Displacement agent, no reporter binding 
CMP-R18-biotin Standard analyte 
CMP-D18-biotin No HSP47 binding 
GST - 
GST-biotin Counter-screen analyte 
 
Determination of optimal analyte concentration 
A grid-screen with varying concentrations of both HSP47 (N-GST) and CMP-R18-biotin served as a 
starting point and allowed determination of the Hook-point. The ratio of acceptor emission intensity to 
donor emission intensity I665nm/I620nm (from now on referred to as signal) was measured in standard assay 
buffer for varying analyte concentrations ranging from 2 nM to 128 nM. As can be seen in Figure 3.27, 
maximum signal to background ratio is observed for the condition containing 16 nM of each analyte, 
and any further increase of analyte concentration leads to signal decrease due to the Hook-effect. For 
following experiments, a working concentration of 10 nM for both analytes was chosen as the standard 
condition.  
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Figure 3.27 │Optimal analyte concentration and Hook-point of the HTRF assay. Dependency of the signal 
to background ratio on analyte concentrations. The signal to background ratio was calculated by dividing the ratio 
of acceptor/donor emission intensity (I665nm/I620nm) for each condition by the averaged ratio of acceptor/donor 
emission intensity of the background. The Hook-effect can be observed under conditions where the concentration 
of either either analyte surpasses 16nM (cyan line).  
 
 
Signal specificity 
With the optimal working concentrations for the analytes established, the specificity of the observed 
signal was examined. Unspecific interactions of HSP47 (N-GST) or the CMP with the reporters were 
investigated via assaying analytes lacking the tags for reporter binding, and could not be detected (Fig 
3.28). Whether the GST-tag undergoes any unspecific interactions with the reporters or the CMP was 
tested via conducting the assay with GST instead of HSP47 (N-GST) in absence as well as presence of 
the CMP, respectively, where no unspecific signal was observed Experiments with loss-of-interaction 
mutations (HSP47D385N and CMP-D18), however, revealed that a small part of the signal cannot be 
attributed to the canonical HSP47 - CMP interaction, which relies largely on the salt bridge between  
D385 in HSP47 and the Arginine in the Yaa position of collagen. A possible source for this signal, 
besides unspecific binding between the analytes, might be the previously mentioned (Section 1.2.4) 
interaction of HSP47 with the GPP motif. 
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Signal stability 
The stability of the signal was measured over the timespan which the screening was anticipated to 
require. Figure 3.29 shows that the signal to background ratio of the established standard condition 
develops over time as the thermodynamic equilibrium is approached. In the control experiments lacking 
either one of the analytes, no significant increase in signal was observed, which would have indicated 
unspecific binding attributable to proteins denaturing over time. 
The DMSO tolerance of the assay has also been shown to be suitable for screening purposes, since no 
significant change in the magnitude of the signal was observed in conditions containing as high as 10% 
(v/v) DMSO (Fig. 3.29, right panel). 
 
Figure 3.28│HTRF assay signal specificity. 
Analytes incapable of reporter-binding show 
no unspecific signal in a grid-screen (top left). 
Similarly, the GST-tag without HSP47 leads 
to a collapse of the signal to background levels 
(top right). Slight binding is observable with 
mutants lacking the ability to form the 
aspartate - arginine salt-bridge (bottom).  
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Figure 3.29│HTRF assay signal stability. The signal doubles over the first hour of incubation and further 
increases by roughly 20% over the measured timespan (left). Inclusion of DMSO did not significantly affect the 
signal, with a roughly 15% decrease compared to the standard condition observed in presence of 10% (v/v) DMSO 
(right). 
 
Assay response to inhibition 
After having established that the observed signal is specific and robust, a competition assay was 
prepared in order to test the response of the assay to inhibitors of the HSP47 – CMP interaction. Due to 
the lack of known inhibitors of the interaction, competition experiments with unbiotinylated CMP were 
conducted. Given that the dynamics of the complex formation allow it (i.e. a sufficiently high koff), the 
untagged CMP should mimic an inhibitor and displace or prevent the binding of a tagged CMP to 
HSP47, leading to a decrease in the signal. This has been observed to be the case, as shown in Fig. 3.30. 
 
 
 
Figure 3.30│Competition assay. The addition of 
unbiotinylated CMP displaces biotinylated CMP 
and leads to a concentration dependent decrease in 
signal to background ratio.  The red line represents 
the logistic fit of the data points.   
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3.5.4 High-throughput Screening 
(The experiments in this section were performed by Andreas Oder at the screening unit of the Leibnitz 
Institute for Molecular Pharmacology in Berlin.)  
After internal testing at the screening facility, the standard assay condition was slightly altered to 
include 3.5 nM HSP47 (N-GST), 7 nM CMP-R18 -biotin, 1.25 ng/well αGST-mAb-Lumi4®-Tb3+-
Cryptate and 25 ng/well SA-XL665 in standard assay buffer, which was further supplemented with 
0.1% (w/v) BSA (vide infra). The reagents were dispensed into the wells of a 384-well plats in the order 
10 µl reporter mixture, 5 µl HSP47 (N-GST), 0.5 µl compound solution and finally 5 µl CMP-R18-
biotin to yield the above stated final concentrations. The plates were incubated for 1 h and read out with 
a Tecan Genios Pro Platereader.  
Statistics based assessment of high-throughput suitability 
The donor and acceptor fluorescence intensities of a 384-well plate with 192 positive and negative 
controls each (i.e. with both analytes present and with HSP47 (N-GST) only, respectively) were read 
out and the Zˈ-factor for their ratio determined as described under 2.4.12. The obtained values, ZˈROBUST: 
0.76, and ZˈSTANDARD: 0.73, indicated that the assay was suitable for high-throughput screening. The 
relevant statistics are displayed in table 3.4.  
Table 3.4│Statistical parameters for determination of the Zˈ-factor 
  
Median 
Median  
absolute Deviation 
 
Mean Value 
Standard 
Deviation 
Positive Controls 1.215 0.061 1.196 0.099 
Negative Controls 0.067 0.001 0.066 0.002 
 
Pilot Screen 
The robustness of the assay towards measurement artefacts stemming from the up-scaling and 
automation as well as from the compounds themselves was tested in a pilot screen. One often 
encountered complication is that assay components adsorb to the tubing or metal tips of the dispenser 
system. This was revealed to be the case for both HSP47 and the CMP in preliminary tests, where 
incubation of either protein in the presence of metal dispenser tips was observed to lead to the collapse 
of signal. The inclusion of 0.1% (w/v) BSA, however, alleviated this problem (Fig 3.31).  
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Figure 3.31│Unspecific interactions of assay components with dispenser system. The donor to acceptor ratio 
of a standard assay condition was determined with and without pre-incubation of each analyte in presence of metal 
dispenser tips. Both HSP47 and the CMP adsorb to the dispenser tips, as is evidenced by the collapse of the signal. 
Utilizing 0.1% BSA as a buffer supplement prevents adsorbtion of the analytes and rescues the signal. Inclusion 
of BSA also leads to a slight increase in signal when neither analyte is subjected to preincubation with dispenser 
tips. 
 
 
The pilot screen was conducted with ten 384-well plates, each with a randomly drawn collection of 368 
compounds as well as 16 wells reserved for positive and negative controls. The compounds were 
administered at a final concentration of 10 µM. The Zˈ-factor for the individual plates ranged from 0.84 
to 0.93 (ZˈROBUST) and from 0.66 to 0.90 (ZˈSTANDARD). 
Primary Screen and Hit Selection 
Table 3.5 gives an overview of the compound libraries used in the primary screen. A total of 40,480 
compounds were tested. The following selection criteria were applied for filtering out artefacts:  
(i) A reduction of at least 15% for the acceptor fluorescence intensity (I665nm) compared to 
the controls 
(ii) -4 ≤ Z-factor ≤ 4 for the donor fluorescence (I620nm) 
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Table 3.5 │ Compound libraries included in the screening 
Library # of Compounds Description 
CBB1 16,544 World Drug Index derived scaffolds based on diversity 
CBB2 7,744 See CBB1; emphasis on solubility 
CBB3 4,576 Carboxylate, ketone and amine fragments 
CBB4 6,688 Selleck library (FDA approved drugs), LOPAC (Aldrich), Artchem 
CBB5 4,928 Donations of academic research labs 
 
336 compounds were observed to increase donor fluorescence, artificially decreasing the signal 
(I665nm/I620nm), and 38,288 compounds failed to satisfy the set criteria. The remaining 1,471 compounds 
were sorted by ascending Z-factor for I665nm/I620nm and the top 352 compounds were selected for IC50-
determination and counter-screening. The average Zˈ-factor of the primary screen was 0.90 ± 0.04. 
IC50-Determination and Counter-screening 
The determination of the IC50-value was conducted in parallel to the counter-screen, in which the 
analytes were substituted for biotinylated GST which bridges the two reporters. The counter-screen 
serves to eliminate any false-positive hits that may arise from alterations of reporter fluorescence 
properties by the compounds. For each of the top 352 compounds, a 1:1 serial dilution ranging from 50 
µM to 0.2 µM was assayed under normal as well as counter-screen conditions.  Compounds which 
satisfied the following criteria were considered suitable for further validation experiments:  
(i) An activity difference of at least 25% (i.e. a difference of at least 25% in I665nm/I620nm 
between the highest and lowest concentrations) 
(ii) A concomittant decrease in I665nm  
(iii) No or a less pronounced activity difference in the counter-screen.  
3.5.5 Experimental Hit-validation 
Hit validation with Biolayer Interferometry 
The high-throughput screening delivered 31 compounds as potential inhibitors, 29 of which were 
provided by the FMP Berlin for further study. The validation was conducted with bio-layer 
interferometry using the Octet system from ForteBio. For this, the association of HSP47 (C-His6) to 
immobilized CMP- R18 -biotin was monitored in presence of 50 µM compound. Figure 3.32 displays 
the maximal response achieved during the experiment as well as the extracted kobs values. 4 compounds 
which induced a notable decrease in either the maximal response (control mean value: 0.99 nm) or kobs 
(control mean value: 0.22 s-1) while at the same time leading to no increase of the other were selected  
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Figure 3.32│Hit validation via biolayer interferometry. The maximal response after 180s (left) and 
corresponding kobs (right) of the association of HSP47 to immobilized CMP-R18-biotin was determined in 
presence of 29 compounds (black and red). In the positive controls, DMSO was added to a final concentration of 
0.5% (w/v) (green) while for negative controls, loading of CMP-R18-biotin on the biosensor was omitted (blue). 
The compounds with the indices 9, 10, 14 and 31 were selected for further verification experiments (red). 
 
for further studies. The data for some compounds were discarded due to unsatisfactory curve fitting or 
the detection of precipitates in the stock solution. 
The inhibitor candidates with the index numbers 14 and 31, from now on referred to as Compound 1 
and 2, respectively, are well-known pharmacologically active molecules and thus commercially 
available; as such, they were the first choice for more in-depth investigation. The efficacy of both 
compounds was scrutinized with HTRF (Fig 3.33). Both compounds seem to have an inhibitory effect, 
with the estimated IC50 values lying in the low micro-molar range for Compound 1 and in the high 
micro-molar range for Compound 2. Analysis of the reporter fluorescence, however, shows that for 
Compound 1 the signal decrease in the concentration range from 1 to 10 µM can be attributed to a 
decrease in donor fluorescence. It should be noted that under the established assay conditions, the 
decrease in donor intensity due to FRET is masked by the presence of excess reporter; this implies that 
Compound 1 is capable of quenching donor fluorescence via an unknown mechanism.  
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Figure 3.33│ Assessment of the efficacy of inhibitor candidates with HTRF. The signal to background ratio 
for the standard assay condition was plotted against different concentrations of compound 1 (1000nM - 1nM, 
black) and compound 2 (333nM - 0.7nM, red) (left). Both compounds are capable of disrupting the HSP47 - 
collagen complex, albeit with rather high IC50 values (low µM for compound 1, high µM for compound 2). 
However, analysis of donor fluorescence intensity I620nm reveals that compound 1 acts as a fluorescence quencher 
and thus is possibly a false positive hit (right). 
 
Compound 2 was subjected to a more detailed analysis via BLI, in which the interaction of HSP47 with 
immobilized CMP-R18
 
was monitored in presence of a serial dilution of the inhibitor candidate (Fig. 
3.34). An estimate of the IC50 value can be given via graphing the maximal response reached in the 
experiment against compound concentration; however, it should be noted that since steady-state was 
not reached, this estimate only serves qualitative purposes. 
 
   
Figure 3.34│ Assessment of the efficacy of inhibitor candidates with BLI. 2.5µM HSP47 were pre-incubated 
in presence of a serial dilution of compound 2 and subsequently the binding curves to immobilized CMP-R18 
recorded via BLI (left). The compound is seen to interfere with complex formation in a concentration dependent 
manner. The maximum response after 60s was plotted against compound concentration to give an estimated IC50 
between 5 - 11µM (right). 
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3.6 Crystallization of HSP47 
The initial focus of crystallization experiments lay on obtaining a low-pH structure of HSP47, with the 
aim of illuminating the molecular details leading to a loss in affinity towards collagen. Unfortunately, 
the intrinsic instability of HSP47 at mildly acidic pH, as previously shown using DSF, has been 
detrimental to these efforts, and it was observed that the protein precipitates overnight in conditions 
with a pH below 7. Similarly, attempts in crystallizing the binding-incompetent mutant H238N, which 
is markedly less stable than the wild type already at pH 7.5, were also not met with success. The focus 
was then shifted on the pH-insensitive mutant H273N + H274N, which did yield crystals, albeit at a pH 
of 7.5 (Fig. 3.35) At this pH, the binding characteristics of the double-mutant are indistinguishable from 
those of wild type HSP47. 
 
Figure 3.35│ Crystals of pH-insensitive mutant H273N + H274N. Left: Crystals of the apo form (Precipitant 
solution: 4% Tacsimate pH 7.0, 18% PEG-3350, 0.1M HEPES (pH 7.5). Middle: Crystals of HSP47 in complex 
with (15)R8 (Precipitant solution: 8% Tacsimate pH 8.0, 19% PEG-3350, 0.1M HEPES (pH 7.5) Right: Crystals 
of HSP47 in complex with (18)T8R11 (Precipitant solution: 5% Tacsimate pH 7.0, 18% PEG-3350, 0.1M HEPES 
(pH 7.5). 
 
 
 
 
 
76 
 
4. Discussion 
4.1 HSP47 function does not require conformational rearrangements  
The perhaps most intriguing aspect of HSP47 is that this molecular chaperone for collagen spawned 
from a family of protease inhibitors. In this regard, HSP47 is not unique among Serpins, since collagen-
binding properties are also attributed PEDF147 and Maspin103. It would be intuitive to suggest that the 
structural and dynamic peculiarities of Serpins, i.e. the meta-stable native structure, the highly flexible 
RCL and the conformational transitions and oligomerizations involving its partial or full insertion into 
β-sheet A, might somehow contribute to the function of HSP47. In line with this assumption, Dafforn 
et al. have previously proposed a “flying-capstan” model for HSP47, in which the protein trimerizes 
via insertion of the RCL of one into the β-sheet of another95. This model originated from the analysis 
of trimeric HSP47, a species routinely detected during purification, which attested it a high 
thermostability with an increase in Tm of up to 20 °C. This remarkable shift in thermal stability is a 
well-known  consequence of RCL insertion, prompting the authors to hypothesize that the observed 
trimeric species is similar to loop-sheet polymers reported for other Serpins, such as α1 anti-trypsin148. 
Koide et al., however, have clearly shown that the trimeric species is not formed in presence of thiol-
alkylating reagents, implying the involvement disulphide-bridges121, and the crystal structure has 
conclusively disproven the flying-capstan model. The conundrum here is that HSP47 does not have the 
capacity to form disulphide-bridged trimers since it harbors only one cysteine. The residue, located 
adjacent to the breach-region in the hinge between β-sheet A and helix E, is furthermore inacessible 
without disruption or translocation of these structural elements. 
As shown in this work, substitution of the native RCL of HSP47 with the larger RCL of α1-antitrypsin 
did not result in a spontaneous transition to the latent conformation; RCL insertion was also not 
triggered upon proteolytic digest. While these were by no means exhaustive studies, with the available 
data it seems improbable that the Serpin-typical conformational transitions are relevant for the function 
of HSP47; a more plausible role for the RCL might be one as an element of interaction with collagens, 
as suggested by its localization close to the binding interface and the finding that the RCL substituted 
mutant has a decreased affinity towards CMPs. The fact that client-binding in HSP47 occurs at the same 
site where protease binding occurs in other serpins evokes the question whether binding to collagen 
serves as protection against proteolytic cleavage.  It is quite possible that the emergence of HSP47 from 
Serpins, which are ancient proteins stretching back to bacteria, can be solely attributed to the fact that 
the latter were simply available in the pool of secretory proteins when the need for a collagen chaperone 
arose. 
Structural analysis shows that HSP47 does not undergo any conformational rearrangements upon client 
binding, since the structure of apo-HSP47 is identical to that of HSP47 in complex with various CMPs. 
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This observation does not exclude pH-induced conformational changes resulting in a binding-
incompetent form, though, since all crystal structures reported in literature122 as well as those obtained 
by the author grew at pH values greater or equal to 7.5, granting insight at the binding competent form 
of HSP47. There might yet exist a low-pH conformation of HSP47; unfortunately, crystallization of 
HSP47 at pH values close to 6.0 has not been successful, presumably due to the decreased stability of 
the protein under such mildly acidic conditions. The presence of such an “acidic” conformation is hinted 
at by spectropolarimetric analysis, which indicates a pronounced change in secondary structure below 
pH 6, as reported by several studies85,149,150. At a physiological pH of 7.2, the circular dichroism 
spectrum of HSP47 is dominated by the broad, negative ellipticity in the region between 208 nm and 
222 nm which is characteristic for folded proteins with a high α-helical content. Lowering the pH 
gradually decreases magnitude of the ellipticity as the pH approaches 6.0; once this threshold is passed, 
a characteristic negative peak emerges at roughly 205 nm. While this process is reversible and adjusting 
the pH back to 7.2 restores the original curve (albeit only after overnight incubation), it remains to be 
proven whether this observed “acidic” state of HSP47 corresponds to a distinct conformation which can 
be associated with client release. The lower magnitude of the ellipticity above 210 nm as well as the 
trend towards negative ellipticity at 195 nm are usually associated with disordered proteins151; 
furthermore, the resemblance to spectra of partially acid-denatured proteins152 is conspicuous. It is quite 
possible that the observed “acidic” conformation is in fact HSP47 which is partially unfolded or in a 
molten globule state. In this work, spectropolarimetry did not reveal any difference in the secondary 
structure of canine HSP47 between pH 7.5 and pH 6.0. Since pH values below 6.0 are not encountered 
by HSP47 in vivo and BLI indicates that a pH of 6.0 is sufficient to drive client dissociation, it is rather 
unlikely that the proposed “acidic” state is of relevancy for the function of HSP47. 
4.2 Molecular Details of Client Release 
4.2.1 On Data Quality in BLI Experiments 
As previously mentioned, determination of the association rate from BLI experiments generally 
suffered from a low precision. This is immediately apparent from Figure 4.1, where the kinetic 
parameters kon and koff, calculated for HSP47WT in different experiments are contrasted. The increasingly 
large average error observed for kon values at low pH presumably reflects the decrease in the thermal 
stability of HSP47 going from pH 7.5 to 6.0: Aggregated or partially unfolded HSP47 would lead to a 
decrease in the concentration of binding-competent protein and presumably increase the probability of 
unspecific interactions with the biosensor. These phenomena are hard to account for and possibly add 
a significant random component to the generated signal. However, the same trend is notably absent in 
case of the koff, where the calculated errors are small and do not discernibly increase at lower pH. 
Dissociation is a first-order reaction and thus independent of free analyte concentration; furthermore, it  
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Figure 4.1│Data variability in BLI experiments. Comparison of the pH dependent kon (left) and koff  (right) 
values determined for HSP47WT over seven different experiments.  
 
 
can be presumed that aggregated, “unhealthy” HSP47 will remain immobilized on the sensor, meaning 
that only the dissociation of intact HSP47 is picked up.  
Another source for the large error accompanying extraction of kon from BLI sensorgrams was the often 
poor fit of the applied monophasic exponential association fit to the data (Fig. A.1). This initially 
prompted the validation of the assumed stoichiometry using ITC, which confirmed the 1:1 Langmuir 
model and suggested that the reasons for the poor fit did not originate from an unsuitable mathematical 
model but rather from the experiment itself. As mentioned in section 3.3.1, the association of HSP47 to 
the CMP loaded biosensor does not reach steady-state in the time frame allowed by the method. Due to 
this, the maximum response is not a defined value, and needs to be approximated during curve fitting.  
The time required to reach equilibrium is correlated to the kinetic parameters as shown in the following 
equations153:  
t1/2 = ln(2) / kobs 
 t1/2 = half-time of equilibration reaction 
 
t97% = 5 ∙ t1/2 
t97% = time required to achieve 97% of the final equilibrium 
 
Since kobs = kon ·  [A] + koff,, the time required for reaching steady state can be calculated from the kinetic 
parameters. For 5 µM HSP47WT at pH 7.5, this yields:  
t97% = 5 ∙ 0.693 / [(35.04 ∙ 103 M-1s-1) ·  (5 ∙ 10-6 M) + 0.028 s-1] = 16.5 s 
Clearly, the time limit imposed by the BLI technique (a maximum of 4 minutes for the association 
phase) should be more than sufficient to reach steady state in case of the HSP47 - CMP interaction. 
While the asymptotic behaviour of the association curve is usually an indication of unspecific binding 
in BLI (as stated by the manufacturer), regeneration of the sensor and repetition of the experiment 
(Eq. 6) 
(Eq. 7) 
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produces nearly identical association curves, which rather defies the definition of unspecific 
interactions.  
Despite these uncertainties, it is clear that the association rates either stay relatively constant over the 
tested pH range or decrease along with the pH. While the accuracy of the determined values for kon and 
KD are certainly disputable, the overall trend does indicate that the increase in koff at lower pH is not 
offset by an increase in kon.  
4.2.2 Characterization of the Histidine Mutants 
The Role of His215 in Collagen Binding 
Abdul-Wahab et al. have previously reported that mutation of either His215 or His216 in murine HSP47 
affects the pH-sensitivity of the collagen interaction150. Corresponding alanine mutants were shown to 
elute early (i.e. at a higher pH) during collagen-affinity chromatography, which was argued to reflect a 
perturbation in pH-dependent, controlled client-release, leading the authors to suggest that these 
residues play a critical role in the pH-switch mechanism. This is partially contradicted by the results 
presented in this work: while H215N and H215N + H216N indeed display a decreased affinity to CMP-
R18, which explains the observed early elution from the gelatin-sepharose column, H216N was 
indistinguishable from the wild-type. Moreover, the weaker binding does not necessarily stand in 
relation to a change in the pH-sensitivity, and accordingly no significant difference in the pH-
dependency of client-release was observed in BLI experiments. 
 
The side-chain His215 comes into close proximity to the Yaa-3 residue on the chain with a register of 
+1 in relation to the chain harbouring the recognized arginine. In cases where this residue is a proline, 
the distance between the tele-nitrogen of the imidazole ring and Cγ of the pyrrolidine ring amounts to 
approximately 4 Å. The interaction lacks a discernible polar component and seems to be hydrophobic 
Figure 4.2│Close-up view of interface 
histidines 215 and 216. The histidines (green) are 
framed by a pair of lysine residues (K213, K217) 
which possibly decrease the pKa values of their 
imidazole side-chains. His215 comes into close 
proximity of Yaa-1 (in this case proline), with a 
distance of 4Å between them (black dashed line). 
Proline hydroxylation overwhelmingly occurs at 
Cγ in the indicated stereochemical configuration 
(red arrow). (PDB ID: 3ZHA) 
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of nature; it is thus unclear why the incorporation of a smaller amino acid such as asparagine disrupts 
client binding in such a magnitude. The sensitivity of the HSP47 - Collagen interaction towards 
disruptions at this site evokes the question whether His215 also partly responsible for the decreased 
affinity of HSP47 to collagens with hydroxyproline in this position, since the 4-hydroxyl group in the 
Cγ-exo pucker would experience increased steric clash with the imidazole moiety. 
The Role of His273 and His274 in Collagen Binding 
In this work it was shown that although His273 and His274 can interchangeably act as the pH-trigger, 
substitutions at position 273 have a larger impact on the pH-sensitivity of the HSP47 - collagen 
interaction, as was the case with H273N and H273A. In agreement with the CpHMD simulations, which 
predict that His273 is substantially more basic (pKa = 5.23) than His274 (pKa ˂ 4), this suggests that 
the pH-trigger role should be attributed to His273, and that His274 merely compensates for this role in 
case His273 is substituted. However, this assumption is called into question by the fact that His274 is 
almost universally conserved in SERPINH1 orthologs, while His273 is commonly found to be replaced 
by asparagine or tyrosine. Taking this into account, a more reasonable model would be that His274 is 
the actual pH-trigger, and that the changes in pH-sensitivity observed for His273 mutants do not arise 
from the loss of protonation at this site but are rather a consequence of an altered microenvironment 
influencing the pKa of His274. A more universal formulation of these findings would be that the pH-
sensitivity of the HSP47 - collagen interaction is by and large determined by the motif Xaa273His274. 
The molecular details, however, are still very much unclear. A closer inspection of the motifs location 
reveals that it is embedded in a 6 residues long loop connecting s4B and hG. With the exception of 
Xaa273, the amino acids comprising this short region are highly conserved in HSP47 orthologs. Since 
the peripheral and solvent-exposed location of this loops renders large contributions to structural 
integrity unlikely, the selection pressure can rather be attributed to functional relevancy. The proline 
residues making up both termini of the loop are strictly conserved and presumably function as secondary 
structure breakers, a feature commonly attributed to prolines due to the absence of a nitrogen-bound 
hydrogen as well as their intrinsic geometric limitations. The XH motif is flanked C-terminally by a 
hydrophobic residue (predominantly valine; methionine and leucine are also encountered in 
Actinopterygii), followed by a glutamic acid (Glu276) residue which forms a salt bridge with an 
arginine located on hG (Arg280). Both of these residues are strictly conserved in HSP47 orthologs as 
well. Together with a hydrogen bond between the backbone carbonyl of Pro272 and the side-chain of 
His386, this interaction seems to lock the loop in place and limit its conformational flexibility. In cases 
where Xaa273 is a histidine, an additional H-bond interaction between the imidazole sidec-chain and 
Asp247 is observed. Comparison of the loop sequences between HSP47, α1-Antitrypsin as well as the 
collagen binding Serpins PEDF and Maspin reveals that the salt-bridge between Glu276 and Arg280 is 
unique to HSP47 (Table 3.6).  
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Table 4.1 │ Sequence comparison of the XH-motif containing loop of HSP47 with selected Serpins 
 
Protein: HSP47 α1-Antitrypsin PEDF Maspin 
Sequence: 272PHHVEP 255PDEGK 259PLKVTQN 233PKDVTG 
 
How exactly the positive charge introduced via protonation of His274 (or His273) perturbs the 
interaction remains subject to speculation. CD spectroscopy did not detect pronounced changes in 
secondary structure between pH 7.5 and 6, nor did the pH-insensitive mutant behave differently than 
the wild-type, suggesting that at most small-scale rearrangements, leading to a distortion of the 
interaction interface, are involved in the pH-switch mechanism. One possible model would be that upon 
protonation, the imidazolium side chain of His274 (or His273) can interact with Glu276, weakening the 
salt-bridge to Arg280 and liberating the loop from its tethering to hG. This could enable the loop to 
“flick” away the collagen client. Alternatively, the loop may directly interfere with the order around the 
nearby intermolecular salt-bridge. 
 
 
Evolution of the XH-motif 
Phylogenetic analysis shows that the identity of the N-terminal amino acid in the XH motif is clade-
specific. In lamprey, the only representative of Hyperoartia for which sequence data is available, this 
residue is a leucine. The most common amino acid encountered in ray-finned fish (Actinopterygii) is 
tyrosine, which is also found in Coalecanth, representative for lobe-finned fish (Sarcopterygii). In 
Tetrapoda, the tyrosine is replaced by either a histidine (Amphibia and Mammalia) or an asparagine 
(Sauropsida), both amino acids being strictly conserved within their respective clades according to 
available data.  
Figure 4.3│Close-up view of interface 
histidines 273 and 274. The histidines are part of 
a 6-residue long loop connecting s4B to hG 
(green). The flexibility of the loop is limited N-
terminally by H-bonds between P272 and H386 
as well as between H273 and D247; C-terminally, 
a salt-bridge between E276 and R280 keeps the 
loop fixed (green dashed lines). The critical salt-
bridge between D385 and R8 is in proximity of 
this loop. 
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Since lamprey are the most ancient vertebrates included in the analysis, it is plausible to assume that 
the LH motif is ancestral to all others. The codon for leucine displays a twofold and fourfold degeneracy 
in the first and third position, respectively; still, only the codon for histidine is accessible via substitution 
of a single nucleobase. Tyrosine and asparagine, on the other hand, can be derived from histidine with 
a single point mutation. Thus, the YH motif of Actinopterygii either emerged from the LH motif via an 
intermediary HH motif, or the HH motif itself is ancestral to all others, the LH motif being a derivative 
of it (Fig. 4.4). 
 
Figure 4.4│ Clade-specific residues encountered in the XH motif are accessible via singular missense             
mutations in the histidine codon. Nucleotide substitution in the first position of the histidine codon gives rise to 
tyrosine or asparagine (green) while mutations in the second position exclusively lead to leucine (red). 
 
4.3 Open Questions regarding the HSP47 - Collagen Interaction 
4.3.1 The Influence of Chain-register on HSP47 Binding is Unknown 
Limitations of Homotrimeric CMPs 
The foldon-domain of bacteriophage T4 fibritin has proven itself an excellent tool for the assembly of 
thermostable collagen model peptides. The stability of the trimer is quite extraordinary: it routinely 
survives the standard protocol for SDS-PAGE sample preparation, which includes 5 minutes of boiling 
in SDS-containing Laemmli buffer. The 27mer appendix further boasts excellent solubility in water and 
introduces a tryptophane residue to the CMP construct, rendering it detectable via UV-spectroscopy. 
One of its innate disadvantages, though, is that foldon-domains do not allow the steered assembly of 
heterotrimeric CMPs with defined composition: the heterotrimeric CMP with the desired register would 
have to be identified and extracted from a mixture of CMPs with nearly identical physical and chemical 
properties, which can be a daunting task. The structural characterization of the HSP47 - collagen 
interaction by Widmer et al. as well as the biophysical characterisation presented in this work were thus 
conducted using homotrimeric CMPs. Since HSP47 interacts with all three α-chains, access to 
heterotrimeric CMPs would allow many open questions regarding structural aspects of the HSP47 - 
collagen interaction to be addressed. For one, it is peculiar that in all available crystal structures, HSP47 
is only seen interacting with arginine residues either in the leading or in the trailing strand. The details 
of this preference could be illuminated with access to heterotrimeric CMPs of the type PRR, RPR, RRP, 
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with one α-chain lacking the arginine in the leading, middle and trailing strand, respectively. 
Furthermore, the register-specific influence of amino-acid substitutions or modifications such as proline 
hydroxylation would be open to investigation. 
Synthetic Heterotrimeric CMPs 
Several strategies for the synthesis of heterotrimeric CMPs have been developed in the past. In cases 
where the α-chain composition or register markedly influences CMP stability, the thermodynamically 
favourable trimer can be enriched via simple cooling of a monomeric (i.e. heated) α-chain mixture154. 
Gauba et al. for instance have steered the self-assembly of a heterotrimeric (α1,α2,α3) CMPs by 
assigning the different α-chains a neutral, positive or negative net charge each, yielding the 
electrostatically neutral species α1α2α3155. More specific synthesis strategies employ orthogonal 
protecting groups to selectively couple α-chains to a trimeric template. This is exemplified by the 
synthesis approach utilized by Li et al., who coupled the trimeric tris(2-aminoethyl)amine (TREN) to 
α1-chains immobilized on a resin at a very low density, ensuring the coupling of only one α1-chain to 
the template. Subsequent attachment of α2 chains in liquid phase yielded a mixture of α1(α2)2 trimers 
which was resolved using HPLC156. In yet another approach, cystine knots are (in analogy to natural 
collagens) introduced between each pair of α-chains via sequential deprotection and oxidation of 
cysteines, allowing the synthesis of heterotrimeric CMPs with a defined composition and register157.  
Heterologous Expression of Heterotrimeric CMPs 
The C-terminal trimerization domains of collagens have been subject to research for over a decade, and 
crystal structures have been obtained for the NC1 domains of collagens I (only homotrimeric 
[α1(I)]3)158, III159, IV160, VIII161, X162, XV163 and XVIII164. Of particular interest among these are the 
trimerization domains of collagens I and IV, since they are able to organize into heterotrimeric isoforms. 
(Collagen I: [α1(I)]2[α2(I)], Collagen IV: [α1(IV)]2[α2(IV)], [α3(IV)][α4(IV)][α5(IV)], 
[α5(IV)]2[α6(IV)]). These domains, however, are rather large and complex, consisting of ~250 residues 
in collagen type I and ~230 residues in collagen type IV. Furthermore, they are subjected to several 
post-translational modifications, including a very unusual crosslink in form of a sulfilimine bond 
between a methionine and a hydroxylysine discovered in the latter type of collagen165. These proteins 
are thus either directly extracted from tissues or expressed in mammalian or insect cells, and an easier 
to produce alternative has been long sought after. Unexpectedly, the ideal candidate for a 
straightforward assembly of heterotrimeric CMPs has not been found among NC1 domains, but rather 
in the NC2 domain of FACIT collagen type IX. This domain not only initiates trimerization and triple-
helix formation independent of the C-Propeptide (NC1)166,167, but is also able to determine chain register 
and grants easy access to heterotrimeric CMPs via heterologous expression in E. coli167. The domain 
consists of three distinct chains, each with a length of 36 or 37 amino acids, and is stabilized by a single 
disulphide bridge between chains α1 and α3.  
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4.4 HSP47 as a Therapeutic Drug Target 
Owing to their unusual size and shape as well as their structural and chemical peculiarities, such as the 
staggered triple-helix or incorporation of hydroxyprolines, collagens impose out of the ordinary 
challenges regarding their production, processing and trafficking. Their biosynthesis is a complex, 
multi-step endeavour which is prone to perturbation at many levels. Of particular importance for 
collagens is the concept of post-translational over-modification, which describes aberrant (i.e. 
excessive) hydroxylation, glycosylation and cross-linking of collagens, resulting in defective proteins 
which are associated with a variety of diseases such as Osteogenesis Imperfecta or the Ehlers-Danlos 
syndrome. HSP47 is a key component for regulating post-translational modifications of collagens, and 
deficiencies in its function typically result in over-modified collagens and the associated pathological 
conditions. Unfortunately, the factors resulting in loss of function are primarily of genetic origin, and 
as such cannot be addressed via conventional drugs. This renders HSP47 an unlikely target (at the 
protein level) for intervention against diseases characterized by collagen overmodification, despite its 
pivotal role in regulating collagen processing.  
The true potential of HSP47 as a therapeutic drug target arises from its involvement in fibrosis. Fibrosis 
is defined as the excessive deposition of fibrous matrix proteins such as fibronectin, laminin and, 
predominantly, of interstitial collagens type I and III168. While the fibrogenic response is an important 
part of benign processes such as scar tissue formation, it can also develop into a pathogenic condition 
when triggered by acute or chronic inflammation169, oxidative stress170 or epithelial injury124. Fibrosis 
is capable of disrupting tissue function and can lead to organ failure and ultimately death171. A common 
hallmark of fibrosis is the upregulation of HSP47 expression levels. This has not only been observed in 
fibrotic diseases such as keloid172, oral submucous fibrosis173 and pulmanory fibrosis174, to name a few, 
but also in complex diseases with fibrotic manifestations, such as systemic sclerosis of skin 
fibroblasts175. Over the last decade, several studies have focused on the silencing of the HSP47 gene in 
order to resolve fibrosis, and siRNA knockdown of the collagen chaperone has been demonstrated to 
resolve fibrosis in cases of liver cirrhosis176 and pancreatic fibrosis177, among others.  
Despite these promising results, the development of small organic molecule inhibitors of the HSP47 - 
Collagen interaction has been left rather orphaned. In an article published 2005, Thomson et al. have 
presented the results of a small-scale (2080 compounds) screening, conducted using their previously 
established assay based on turbidimetric measurement of collagen fibril formation116. This resulted in 
the identification of 4 compounds as potential inhibitors of the HSP47 - Collagen interaction178. Pillai 
et al. utilized in-silico docking studies to identify HSP47 binders among a library of known natural 
products. Of each study, one compound was acquired and tested for its inhibitory potential using BLI; 
however, in both cases no inhibitory activity was observed (Fig. A.2).  
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The following features of HSP47 make it stand out as an attractive target for anti-fibrotic treatment:  
(i) It fulfils a highly specialized role, interacting primarily with collagen and, to a lesser 
extent, with other collagen-modifying or recognizing proteins such as LH2 or 
TANGO1. This limits the effects of HSP47 inhibition to collagen biosynthesis. 
(ii) Although the pathogenesis and progression of fibrosis is influenced by numerous 
different factors, all fibrotic diseases ultimately converge on excessive collagen 
deposition. Thus, intervening at this point would ensure a broad range of application 
for the treatment. 
Notwithstanding the latter point, coverage of the whole spectrum of diseases with fibrotic 
manifestations would be well beyond the scope of this work, and the discussion will thus rather focus 
on skin fibrosis, since the research was conducted in context of investigating molecular mechanisms 
regulating skin homeostasis. Currently available treatment options for dermal fibrosis are surgical 
excision, targeting of the inflammatory response with corticosteroids, or anti-sense oligonucleotide 
treatment directed against various key elements in the fibrotic cascade such as TGF-β or LOX179. An 
endostatin-derived peptide (E4) has been shown to ameliorate TGF-β or bleomycin induced skin 
fibrosis180 and its efficacy as an orally bioavailable, potent anti-fibrotic agent in animal models is well 
established181. According to the clinical trial registry of the US National Institute of Health 
(www.clinicaltrials.gov), the efficacy of Pirfenidone (5-methyl-1-phenyl-2-(1H)-pyridone), an anti-
fibrotic drug indicated for the treatment of idiopathic pulmanory fibrosis, is currently under evaluation 
for the treatment skin fibrosis associated to systemic sclerosis. Interestingly, one of the observed effects 
of Pirfenidone treatment is the inhibition of increased HSP47 expression induced by TGF-β1182; 
however, it is unclear whether this is tied to the concurrently observed reduction of collagen type I 
production, the expression of which is known to be tied to that of HSP47. 
To summarize, small organic molecules which allow the modulation or inhibition of the HSP47 - 
collagen interaction are not only of interest as research tools, but are also promising candidates for anti-
fibrotic drugs. As such, the author hopes that the work laid out in this thesis may provide a small but 
nevertheless worthwhile initial step (i.e. a promising lead structure) in the development of therapeutic 
means to combat fibrosis. 
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Figure A.1│ Sensorgrams of the interaction of wild-type and mutant HSP47 with CMP-R18 at various pH. 
The binding of 2.5µM HSP47 to immobilized CMP-R18 was monitored via BLI at various pH. The pH 
corresponding to the individual binding curves is indicated for the wild-type. The association and dissociation 
phases were fitted separately using a monophasic exponential function (green and red curves) to yield the kon and 
koff values, respectively. 
 
 
  
Figure A.2│ BLI testing of inhibitor efficacy. The binding HSP47 to immobilized CMP-R18 was monitored in 
presence of a serial dilution of compounds reported to inhibit HSP47 - collagen complex formation by Katarkar 
et al.183 (red) or Thomson et al.178(black). The concentration of HSP47 was 1.5µM and 2.5µM, respectively. The 
8-digit numbers represent the ZINC database ID of the compounds. An effect of the compounds on the HSP47 - 
CMP interaction was not observed. 
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A.2 Tables 
 
Table A.1│Client-dissociation rates of HSP47 mutants at various pH values  
 
 koff / s-1 
 pH 7.5 pH 7.0 pH 6.5 pH 6.0 
WT 0.028 ± 0.000 0.042 ± 0.001 0.075 ± 0.001 0.192 ± 0.002 
H153N 0.029 ± 0.001 0.045 ± 0.001 0.074 ± 0.006 0.179 ± 0.003 
H158N 0.031 ± 0.003 0.045 ± 0.001 0.070 ± 0.002 0.187 ± 0.002 
H215N 0.097 ± 0.005 0.126 ± 0.005 0.159 ± 0.015 0.313 ± 0.023 
H216N 0.039 ± 0.001 0.055 ± 0.003 0.088 ± 0.004 0.184 ± 0.013 
H215N + H216N 0.094 ± 0.002 0.124 ± 0.003 0.168 ± 0.019 0.273 ± 0.005 
H238N n.d. n.d. n.d. n.d. 
H262N 0.030 ± 0.001 0.047 ± 0.004 0.096 ± 0.002 0.236 ± 0.018 
H273N 0.028 ± 0.001 0.038 ± 0.003 0.063 ± 0.003 0.148 ± 0.009 
H274N 0.029 ± 0.001 0.038 ± 0.001 0.075 ± 0.004 0.170 ± 0.010 
H273N + H274N 0.024 ± 0.001 0.026 ± 0.001 0.038 ± 0.002 0.071 ± 0.002 
H273A 0.023 ± 0.002 0.030 ± 0.002 0.048 ± 0.004 0.111 ± 0.002 
H274A 0.029 ± 0.001 0.036 ± 0.002 0.071 ± 0.008 0.169 ± 0.005 
H273A + H274A 0.028 ± 0.002 0.031 ± 0.001 0.043 ± 0.002 0.080 ± 0.002 
H273D 0.020 ± 0.001 0.028 ± 0.001 0.051 ± 0.002 0.110 ± 0.003 
H273K 0.023 ± 0.001 0.034 ± 0.001 0.057 ± 0.005 0.134 ± 0.006 
H274D 0.024 ± 0.001 0.032 ± 0.002 0.048 ± 0.004 0.100 ± 0.002 
H274K 0.103 ± 0.010 0.124 ± 0.012 0.167 ± 0.006 0.285 ± 0.011 
H273F 0.022 ± 0.000 0.029 ± 0.000 0.050 ± 0.002 0.139 ± 0.003 
H273L 0.017 ± 0.000 0.024 ± 0.001 0.039 ± 0.001 0.112 ± 0.002 
H273Y 0.029 ± 0.001 0.043 ± 0.003 0.076 ± 0.002 0.215 ± 0.001 
 
IV 
 
Table A.2│ Client-association rates of HSP47 mutants at various pH values 
 
 
 
 
 
 
 
 
 
 kon / mM-1·s-1 
 pH 7.5 pH 7.0 pH 6.5 pH 6.0 
WT 35.04±2.31 34.24±0.95 30.82±0.12 28.96±2.48 
H153N 38.03±0.93 34.28±0.94 38.88±3.89 29.82±0.58 
H158N 56.19±1.50 45.44±3.68 51.33±3.37 49.51±6.59 
H215N 61.06±5.44 57.60±5.50 44.56±6.71 35.08±3.68 
H216N 32.90±2.81 35.67±1.38 32.48±3.34 23.98±6.29 
H215N + H216N 57.86±3.78 57.72±3.75 40.09±10.19 59.57±6.05 
H238N n.d. n.d. n.d. n.d. 
H262N 45.31±3.38 42.49±7.74 37.77±1.54 24.67±8.63 
H273N 28.67±0.17 30.15 ± 0.67 27.17±2.18 21.75±4.81 
H274N 44.19±1.52 41.75±2.26 35.93±2.82 29.33±2.71 
H273N + H274N 27.86±2.57 30.80±0.19 30.27±0.77 27.19±0.10 
H273A 28.23±2.60 20.38±1.78 18.41±0.40 18.63±3.68 
H274A 23.89±2.11 31.99±1.35 30.10±1.56 26.39±6.29 
H273A + H274A 26.29±0.63 31.42±1.67 25.74±2.55 27.11±6.05 
H273D 31.47±1.48 31.34±0.83 29.37±0.41 27.87±4.40 
H273K 33.41±0.36 30.66±0.54 28.76±5.49 26.65±2.46 
H274D 32.54±0.33 29.38±3.39 34.48±2.67 25.18±2.68 
H274K 21.65±2.91 17.46±0.91 11.415±2.83 5.02±3.63 
H273F 35.58±2.08 30.19±5.46 23.38±4.14 25.77±0.34 
H273L 37.57±4.94 32.91±2.01 30.89±0.67 29.45±2.33 
H273Y 35.07±0.69 28.24±3.22 24.05±0.71 20.84±3.79 
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Table A.3│ Client-dissociation constants of HSP47 mutants at various pH values 
 
 KD / µM 
 pH 7.5 pH 7.0 pH 6.5 pH 6.0 
WT 0.74 ± 0.02 1.14 ± 0.04 2.25 ± 0.24 6.23 ± 0.88 
H153N 0.76 ± 0.02 1.20 ± 0.04 1.93 ± 0.36 6.00 ± 0.21 
H158N 0.55 ± 0.05 1.00 ± 0.08 1.38 ± 0.13 3.85 ± 0.52 
H215N 1.60 ± 0.19 2.21 ± 0.27 3.70 ± 0.96 8.93 ± 1.20 
H216N 1.18 ± 0.08 1.55 ± 0.14 2.76 ± 0.04 7.65 ± 1.93 
H215N + H216N 1.63 ± 0.12 2.15 ± 0.12 4.70 ± 1.96 4.58 ± 0.92 
H238N n.d. n.d. n.d. n.d. 
H262N 0.67 ± 0.06 1.13 ± 0.20 2.55 ± 0.17 11.39 ± 5.18 
H273N 0.97 ± 0.04 1.27 ± 0.13 2.34 ± 0.29 7.27 ± 2.01 
H274N 0.65 ± 0.03 0.92 ± 0.05 2.12 ± 0.26 5.86 ± 0.75 
H273N + H274N 0.85 ± 0.09 0.86 ± 0.02 1.26 ± 0.09 2.60 ± 0.08 
H273A 0.82 ± 0.09 1.48 ± 0.21 2.58 ± 0.16 6.21 ± 1.20 
H274A 1.23 ± 0.12 1.12 ± 0.05 2.37 ± 0.19 6.85 ± 1.93 
H273A + H274A 1.07 ± 0.07 1.00 ± 0.06 1.69 ± 0.22 3.17 ± 0.92 
H273D 0.64 ± 0.04 0.89 ± 0.02 1.74 ± 0.07 4.04 ± 0.58 
H273K 0.69 ± 0.02 1.09 ± 0.06 2.11 ± 0.56 5.08 ± 0.67 
H274D 0.73 ± 0.04 1.11 ± 0.18 1.40 ± 0.07 4.02 ± 0.44 
H274K 2.98 ± 0.28 3.40 ± 0.78 5.17 ± 0.81 16.29 ± 7.56 
H273F 0.61 ± 0.04 1.01 ± 0.20 2.20 ± 0.32 5.39 ± 0.20 
H273L 0.47 ± 0.06 0.72 ± 0.06 1.28 ± 0.06 3.84 ± 0.26 
H273Y 0.83 ± 0.02 1.53 ± 0.24 3.16 ± 0.20 10.37 ± 1.90 
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Table A.4│ Primers for Site-directed Mutagenesis 
 
    Primer                                                                   Sequence 
H153N-Fw GCAGAACTACAATTGCGAG 
H153N-Rv CAATTGTAGTTCTGCTTGCTGCT 
H158N-Fw CGAGAACAGCAAAATCAACTTTC 
H158N-Rv GATTTTGCTGTTCTCGCAATTGT 
H215N-Fw AATTTCAATCACAAAATGGTCGAT 
H215N-Rv TTTGTGATTGAATTTCTCATCCCA 
H216N-Fw TTCCACAATAAAATGGTCGATAAT 
H216N-Rv CATTTTATTGTGGAATTTCTCATC 
H215N+H216N-Fw TTCGCCGCCAAAATGGTCGATAATC 
H215N+H216N-Rv CATTTTGGCGGCGAATTTCTCATC 
H262N-Fw GGCCAACAAGCTGTCCTCTC 
H262N-Rv GCTTGTTGGCCAGCGGC 
H273A-Fw ATGCCGGCTCACGTGGAGCCGCTG 
H273A-Rv CACGTGAGCCGGCATCAAGATGATC 
H273D-Fw ATGCCGGACCACGTGGAGCC 
H273D-Rv ACGTGGTCCGGCATCAAGATGATC 
H273F-Fw ATGCCGTTTCACGTGGAGCC 
H273F-Rv CACGTGAAACGGCATCAAGATG 
H273K-Fw ATGCCGAAGCACGTGGAGCC 
H273K-Rv ACGTGCTTCGGCATCAAGATGATC 
H273L-Fw ATGCCGCTTCACGTGGAGCC 
H273L-Rv CACGTGAAGCGGCATCAAGATG 
H273Y-Fw ATGCCGTATCACGTGGAGCC 
H273Y-Rv CACGTGATACGGCATCAAGATG 
H274A-Fw CCGCATGCCGTGGAGCCGCTGGAGC 
H274A-Rv CTCCACGGCATGCGGCATCAAGATC 
H274D-Fw CCGCATGACGTGGAGCCGCTGGAGC 
H274D-Rv CTCCACGTCATGCGGCATCAAG 
H274K-Fw CGCATAAGGTGGAGCCGCTG 
H274K-Rv CTCCACCTTATGCGGCATCAAGATC 
H274A+H274A-Fw CCGGCTGCCGTGGAGCCGCTG 
H274A+H274A-Rv CTCCACGGCAGCCGGCATCAAGATC 
H315N-Fw GTAACGAACGATCTGCAGAAAC 
H315N-Rv GATCGTTCGTAACTTCGACCAC 
Y383F-Fw CTGTTTTTCGCGGATCATCCG 
Y383F-Rv GATGATCCGCGAAAAAACAGC 
D385N-Fw TTACGCGAATCATCCGTTCATTTTCCTG 
D385N-Rv GGATGATTCGCGTAAAACAGCTTCG 
HSP47 -Cstrep +XhoI ATACTCGAGCAGCTCATCGCGCATTTTG 
R222A-Fw GATAATGCAGGTTTCATGGTTAC 
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(continued) Table A.4│ Primers for Site-directed Mutagenesis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Primer   Sequence 
  R222A-Rw GAAACCTGCATTATCGACCATTT 
R222E-Fw GATAATAAGGGTTTCATGGTTAC 
R222E-Rv GAAACCCTTATTATCGACCATTT 
R222K-Fw GATAATGAGGGTTTCATGGTTAC 
R222K-Rv GAAACCCTCATTATCGACCATTT 
D247A-Fw TACTACGCAGACGAAAAAGAGAAAC 
D247A-Rv TTCGTCTGCGTAGTAGTTATACAGAC 
VIII 
 
Table A.5│ Crystallization Screen 1 & 2 (Low-Tacsimate, High and Low pH) 
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10% H 
2%TM 
22% P 
10% H 
2% T8 
22% P 
10% H 
3% T7 
22% P 
10% H 
3%TM 
22% P 
10% H 
3% T8 
22% P 
10% H 
4% T7 
22% P 
10% H 
4%TM 
22% P 
10% H 
4% T8 
22% P 
10% H 
5% T7 
22% P 
10% H 
5%TM 
22% P 
10% H 
5% T8 
22% P 
10% H 
6% T7 
22% P 
10% H 
6%TM 
22% P 
10% H 
6% T8 
22% P 
10% H 
7% T7 
22% P 
10% H 
7%TM 
22% P 
10% H 
7% T8 
22% P 
10% H 
8% T7 
22% P 
10% H 
8%TM 
22% P 
10% H 
8% T8 
22% P 
10% H 
 
% = percent volume 
T7 = Tacsimate (pH 7), TM = 1:1 mixture Tacsimate (pH 7) and Tacsimate (pH 8), T8 = Tacsimate (pH 8) 
P = PEG-3350 
H = 1M HEPES (pH 7.5 or pH 6) 
 
Table A.6│ Crystallization Screens 3 & 4 (High-Tacsimate, High and Low pH) 
 
9% T7 
16% P 
10% H 
9%TM 
16% P 
10% H 
9% T8 
16% P 
10% H 
10% T7 
16% P 
10% H 
10%TM 
16% P 
10% H 
10% T8 
16% P 
10% H 
11% T7 
16% P 
10% H 
11%TM 
16% P 
10% H 
11% T8 
16% P 
10% H 
12% T7 
16% P 
10% H 
12%TM 
16% P 
10% H 
12% T8 
16% P 
10% H 
13% T7 
16% P 
10% H 
13%TM 
16% P 
10% H 
13% T8 
16% P 
10% H 
14% T7 
16% P 
10% H 
14%TM 
16% P 
10% H 
14% T8 
16% P 
10% H 
15% T7 
16% P 
10% H 
15%TM 
16% P 
10% H 
15% T8 
16% P 
10% H 
16% T7 
16% P 
10% H 
16%TM 
16% P 
10% H 
16% T8 
16% P 
10% H 
9%  T7 
18% P 
10% H 
9% TM 
18% P 
10% H 
9%  T8 
18% P 
10% H 
10% T7 
18% P 
10% H 
10%TM 
18% P 
10% H 
10% T8 
18% P 
10% H 
11% T7 
18% P 
10% H 
11%TM 
18% P 
10% H 
11% T8 
18% P 
10% H 
12% T7 
18% P 
10% H 
12%TM 
18% P 
10% H 
12% T8 
18% P 
10% H 
13% T7 
18% P 
10% H 
13%TM 
18% P 
10% H 
13% T8 
18% P 
10% H 
14% T7 
18% P 
10% H 
14%TM 
18% P 
10% H 
14% T8 
18% P 
10% H 
15% T7 
18% P 
10% H 
15%TM 
18% P 
10% H 
15% T8 
18% P 
10% H 
16% T7 
18% P 
10% H 
16%TM 
18% P 
10% H 
16% T8 
18% P 
10% H 
9%  T7 
20% P 
10% H 
9% TM 
20% P 
10% H 
9%  T8 
20% P 
10% H 
10% T7 
20% P 
10% H 
10%TM 
20% P 
10% H 
10% T8 
20% P 
10% H 
11% T7 
20% P 
10% H 
11%TM 
20% P 
10% H 
11% T8 
20% P 
10% H 
12% T7 
20% P 
10% H 
12%TM 
20% P 
10% H 
12% T8 
20% P 
10% H 
13% T7 
20% P 
10% H 
13%TM 
20% P 
10% H 
13% T8 
20% P 
10% H 
14% T7 
20% P 
10% H 
14%TM 
20% P 
10% H 
14% T8 
20% P 
10% H 
15% T7 
20% P 
10% H 
15%TM 
20% P 
10% H 
15% T8 
20% P 
10% H 
16% T7 
20% P 
10% H 
16%TM 
20% P 
10% H 
16% T8 
20% P 
10% H 
9%  T7 
22% P 
10% H 
9%TM 
22% P 
10% H 
9% T8 
22% P 
10% H 
10% T7 
22% P 
10% H 
10%TM 
22% P 
10% H 
10% T8 
22% P 
10% H 
11% T7 
22% P 
10% H 
11%TM 
22% P 
10% H 
11% T8 
22% P 
10% H 
12% T7 
22% P 
10% H 
12%TM 
22% P 
10% H 
12% T8 
22% P 
10% H 
13% T7 
22% P 
10% H 
13%TM 
22% P 
10% H 
13% T8 
22% P 
10% H 
14% T7 
22% P 
10% H 
14%TM 
22% P 
10% H 
14% T8 
22% P 
10% H 
15% T7 
22% P 
10% H 
15%TM 
22% P 
10% H 
15% T8 
22% P 
10% H 
16% T7 
22% P 
10% H 
16%TM 
22% P 
10% H 
16% T8 
22% P 
10% H 
 
% = percent volume 
T7 = Tacsimate (pH 7), TM = 1:1 mixture Tacsimate (pH 7) and Tacsimate (pH 8), T8 = Tacsimate (pH 8) 
P = PEG-3350 
H = 1M HEPES (pH 7.5 or pH 6) 
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